|
Code
|
Display
|
|
14682-9
|
Creatinine [Moles/volume] in Serum or Plasma |
|
718-7
|
Hemoglobin [Mass/volume] in Blood |
|
2823-3
|
Potassium [Moles/volume] in Serum or Plasma |
|
14749-6
|
Glucose [Moles/volume] in Serum or Plasma |
|
2951-2
|
Sodium [Moles/volume] in Serum or Plasma |
|
3094-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma |
|
2028-9
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma |
|
2075-0
|
Chloride [Moles/volume] in Serum or Plasma |
|
789-8
|
Erythrocytes [#/volume] in Blood by Automated count |
|
786-4
|
Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count |
|
785-6
|
Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count |
|
2000-8
|
Calcium [Moles/volume] in Serum or Plasma |
|
15074-8
|
Glucose [Moles/volume] in Blood |
|
4544-3
|
Hematocrit [Volume Fraction] of Blood by Automated count |
|
6690-2
|
Leukocytes[#/volume] in Blood by Automated count |
|
1742-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
|
787-2
|
Erythrocyte mean corpuscular volume [Entitic volume] by Automated count |
|
777-3
|
Platelets [#/volume] in Blood by Automated count |
|
1920-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
|
1751-7
|
Albumin [Mass/volume] in Serum or Plasma |
|
14631-6
|
Bilirubin.total [Moles/volume] in Serum or Plasma |
|
2885-2
|
Protein [Mass/volume] in Serum or Plasma |
|
6768-6
|
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
788-0
|
Erythrocyte distribution width [Ratio] by Automated count |
|
770-8
|
Neutrophils/100 leukocytes in Blood by Automated count |
|
33914-3
|
Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) |
|
704-7
|
Basophils [#/volume] in Blood by Automated count |
|
20570-8
|
Hematocrit [Volume Fraction] of Blood |
|
48642-3
|
Glomerular filtration rate/1.73 sq M predicted among non-blacks by Creatinine-based formula (MDRD) |
|
48643-1
|
Glomerular filtration rate/1.73 sq M predicted among blacks by Creatinine-based formula (MDRD) |
|
26515-7
|
Platelets [#/volume] in Blood |
|
14647-2
|
Cholesterol [Moles/volume] in Serum or Plasma |
|
26464-8
|
Leukocytes [#/volume] in Blood |
|
30428-7
|
Erythrocyte mean corpuscular volume [Entitic volume] |
|
731-0
|
Lymphocytes [#/volume] in Blood by Automated count |
|
14927-8
|
Triglyceride [Moles/volume] in Serum or Plasma |
|
10466-1
|
Anion gap 3 in Serum or Plasma |
|
14646-4
|
Cholesterol in HDL [Moles/volume] in Serum or Plasma |
|
6463-4
|
Bacteria identified in Unspecified specimen by Culture |
|
26485-3
|
Monocytes/100 leukocytes in Blood |
|
736-9
|
Lymphocytes/100 leukocytes in Blood by Automated count |
|
706-2
|
Basophils/100 leukocytes in Blood by Automated count |
|
713-8
|
Eosinophils/100 leukocytes in Blood by Automated count |
|
5905-5
|
Monocytes/100 leukocytes in Blood by Automated count |
|
26478-8
|
Lymphocytes/100 leukocytes in Blood |
|
751-8
|
Neutrophils [#/volume] in Blood by Automated count |
|
5902-2
|
Prothrombin time (PT) |
|
33069-6
|
Fetal Neck.soft tissue Translucency width US |
|
26450-7
|
Eosinophils/100 leukocytes in Blood |
|
711-2
|
Eosinophils [#/volume] in Blood by Automated count |
|
22637-3
|
Pathology report final diagnosis |
|
742-7
|
Monocytes [#/volume] in Blood by Automated count |
|
6301-6
|
INR in Platelet poor plasma by Coagulation assay |
|
30180-4
|
Basophils/100 leukocytes in Blood |
|
3097-3
|
Urea nitrogen/Creatinine [Mass ratio] in Serum or Plasma |
|
5802-4
|
Nitrite [Presence] in Urine by Test strip |
|
26499-4
|
Neutrophils [#/volume] in Blood |
|
5778-6
|
Color of Urine |
|
5803-2
|
pH of Urine by Test strip |
|
1759-0
|
Albumin/Globulin [Mass ratio] in Serum or Plasma |
|
26484-6
|
Monocytes [#/volume] in Blood |
|
10834-0
|
Globulin [Mass/volume] in Serum by calculation |
|
39469-2
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation |
|
5770-3
|
Bilirubin [Presence] in Urine by Test strip |
|
5799-2
|
Leukocyte esterase [Presence] in Urine by Test strip |
|
5767-9
|
Appearance of Urine |
|
26449-9
|
Eosinophils [#/volume] in Blood |
|
66126-4
|
Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation |
|
14879-1
|
Phosphate [Moles/volume] in Serum or Plasma |
|
26474-7
|
Lymphocytes [#/volume] in Blood |
|
5811-5
|
Specific gravity of Urine by Test strip |
|
5794-3
|
Hemoglobin [Presence] in Urine by Test strip |
|
22705-8
|
Glucose [Moles/volume] in Urine by Test strip |
|
5804-0
|
Protein [Mass/volume] in Urine by Test strip |
|
11579-0
|
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
|
26511-6
|
Neutrophils/100 leukocytes in Blood |
|
3173-2
|
Activated partial thromboplastin time (aPTT) in Blood by Coagulation assay |
|
2601-3
|
Magnesium [Moles/volume] in Serum or Plasma |
|
5821-4
|
Leukocytes [#/area] in Urine sediment by Microscopy high power field |
|
22702-5
|
Ketones [Moles/volume] in Urine by Test strip |
|
4548-4
|
Hemoglobin A1c/Hemoglobin.total in Blood |
|
14629-0
|
Bilirubin.direct [Moles/volume] in Serum or Plasma |
|
2336-6
|
Globulin [Mass/volume] in Serum |
|
11555-0
|
Base excess in Blood |
|
47527-7
|
Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep |
|
11557-6
|
Carbon dioxide [Partial pressure] in Blood |
|
11556-8
|
Oxygen [Partial pressure] in Blood |
|
22636-5
|
Pathology report relevant history |
|
5769-5
|
Bacteria [#/area] in Urine sediment by Microscopy high power field |
|
2157-6
|
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
|
32309-7
|
Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
22748-8
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma |
|
630-4
|
Bacteria identified in Urine by Culture |
|
2713-6
|
Oxygen saturation.calculated from oxygen partial pressure in Blood |
|
22638-1
|
Pathology report comments |
|
11558-4
|
pH of Blood |
|
22639-9
|
Pathology report supplemental reports |
|
20454-5
|
Protein [Presence] in Urine by Test strip |
|
13945-1
|
Erythrocytes [#/area] in Urine sediment by Microscopy high power field |
|
738-5
|
Macrocytes [Presence] in Blood by Light microscopy |
|
2514-8
|
Ketones [Presence] in Urine by Test strip |
|
741-9
|
Microcytes [Presence] in Blood by Light microscopy |
|
19146-0
|
Reference lab test results |
|
3016-3
|
Thyrotropin [Units/volume] in Serum or Plasma |
|
6298-4
|
Potassium [Moles/volume] in Blood |
|
34927-4
|
Urobilinogen [Moles/volume] in Urine |
|
19764-0
|
Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
|
19767-3
|
Cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
|
19763-2
|
Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
13969-1
|
Creatine kinase.MB [Mass/volume] in Serum or Plasma |
|
18314-5
|
Morphology [interpretation] in Blood Narrative |
|
10839-9
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma |
|
19773-1
|
Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
19769-9
|
Pathologist who read Cyto stain of Cervical or vaginal smear or scraping |
|
2349-9
|
Glucose [Presence] in Urine |
|
34928-2
|
Urobilinogen [Moles/volume] in Urine by Test strip |
|
33037-3
|
Anion gap in Serum or Plasma |
|
728-6
|
Hypochromia [Presence] in Blood by Light microscopy |
|
1959-6
|
Bicarbonate [Moles/volume] in Blood |
|
26444-0
|
Basophils [#/volume] in Blood |
|
2965-2
|
Specific gravity of Urine |
|
23658-8
|
Other Antibiotic [Susceptibility] |
|
2857-1
|
Prostate specific Ag [Mass/volume] in Serum or Plasma |
|
14630-8
|
Bilirubin.indirect [Moles/volume] in Serum or Plasma |
|
20409-9
|
Erythrocytes [#/volume] in Urine by Test strip |
|
14635-7
|
Calcidiol [Moles/volume] in Serum or Plasma |
|
8247-9
|
Mucus [Presence] in Urine sediment by Light microscopy |
|
2947-0
|
Sodium [Moles/volume] in Blood |
|
1994-3
|
Calcium.ionized [Moles/volume] in Blood |
|
600-7
|
Bacteria identified in Blood by Culture |
|
6742-1
|
Erythrocyte morphology finding [Identifier] in Blood |
|
14920-3
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
|
5818-0
|
Urobilinogen [Presence] in Urine by Test strip |
|
44915-7
|
Cholesterol in LDL/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
764-1
|
Neutrophils.band form/100 leukocytes in Blood by Manual count |
|
4537-7
|
Erythrocyte sedimentation rate by Westergren method |
|
8310-5
|
Body temperature |
|
3040-3
|
Lipase [Enzymatic activity/volume] in Serum or Plasma |
|
14798-3
|
Iron [Moles/volume] in Serum or Plasma |
|
9317-9
|
Platelets [Presence] in Blood by Light microscopy |
|
14933-6
|
Urate [Moles/volume] in Serum or Plasma |
|
20565-8
|
Carbon dioxide, total [Moles/volume] in Blood |
|
925-8
|
Blood product disposition [Type] |
|
14921-1
|
Thyroxine (T4) [Moles/volume] in Serum or Plasma |
|
13317-3
|
Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture |
|
14979-9
|
Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay |
|
11277-1
|
Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field |
|
32623-1
|
Platelet mean volume [Entitic volume] in Blood by Automated count |
|
14685-2
|
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
|
20453-7
|
Epithelial cells [Presence] in Urine sediment by Light microscopy |
|
1798-8
|
Amylase [Enzymatic activity/volume] in Serum or Plasma |
|
2276-4
|
Ferritin [Mass/volume] in Serum or Plasma |
|
1988-5
|
C reactive protein [Mass/volume] in Serum or Plasma |
|
5808-1
|
Erythrocytes [#/volume] in Urine sediment by Microscopy high power field |
|
2532-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
14800-7
|
Iron binding capacity [Moles/volume] in Serum or Plasma |
|
5782-8
|
Crystals [type] in Urine sediment by Light microscopy |
|
21000-5
|
Erythrocyte distribution width [Entitic volume] by Automated count |
|
2753-2
|
pH of Serum or Plasma |
|
14683-7
|
Creatinine [Moles/volume] in Urine |
|
20408-1
|
Leukocytes [#/volume] in Urine by Test strip |
|
27045-4
|
Microscopic exam [interpretation] of Urine by Cytology |
|
31100-1
|
Hematocrit [Volume Fraction] of Blood by Impedance |
|
11580-8
|
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
|
5787-7
|
Epithelial cells [#/area] in Urine sediment by Microscopy high power field |
|
735-1
|
Lymphocytes Variant/100 leukocytes in Blood by Manual count |
|
934-0
|
Blood product unit ID [#] |
|
882-1
|
ABO & Rh group [Type] in Blood |
|
19161-9
|
Urobilinogen [Units/volume] in Urine by Test strip |
|
70199-5
|
Bilirubin.total [Moles/volume] in Urine |
|
30167-1
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe & signal amplification method |
|
20507-0
|
Reagin Ab [Presence] in Serum by RPR |
|
3151-8
|
Inhaled oxygen flow rate |
|
14957-5
|
Microalbumin [Mass/volume] in Urine |
|
58448-2
|
Microalbumin ug/min [Mass/time] in 24 hour Urine |
|
26508-2
|
Neutrophils.band form/100 leukocytes in Blood |
|
24111-7
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
11279-7
|
Urine sediment comments by Light microscopy Narrative |
|
21613-5
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
14732-2
|
Folate [Moles/volume] in Serum or Plasma |
|
1995-0
|
Calcium.ionized [Moles/volume] in Serum or Plasma |
|
11282-1
|
Cells Counted Total [#] in Blood |
|
2106-3
|
Choriogonadotropin (pregnancy test) [Presence] in Urine |
|
933-2
|
Blood product type |
|
737-7
|
Lymphocytes/100 leukocytes in Blood by Manual count |
|
2744-1
|
pH of Arterial blood |
|
30313-1
|
Hemoglobin [Mass/volume] in Arterial blood |
|
10378-8
|
Polychromasia [Presence] in Blood by Light microscopy |
|
2324-2
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
|
25162-9
|
Hyaline casts [Presence] in Urine sediment by Light microscopy |
|
14801-5
|
Iron saturation [Molar fraction] in Serum or Plasma |
|
2703-7
|
Oxygen [Partial pressure] in Arterial blood |
|
664-3
|
Microscopic observation [Identifier] in Unspecified specimen by Gram stain |
|
3879-4
|
Opiates [Presence] in Urine |
|
3390-2
|
Benzodiazepines [Presence] in Urine |
|
53553-4
|
Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin |
|
890-4
|
Blood group antibody screen [Presence] in Serum or Plasma |
|
26507-4
|
Neutrophils.band form [#/volume] in Blood |
|
3050-2
|
Triiodothyronine resin uptake (T3RU) in Serum or Plasma |
|
30405-5
|
Leukocytes [#/volume] in Urine |
|
48345-3
|
HIV 1+O+2 Ab [Presence] in Serum or Plasma |
|
14913-8
|
Testosterone [Moles/volume] in Serum or Plasma |
|
30934-4
|
Natriuretic peptide B [Mass/volume] in Serum or Plasma |
|
2019-8
|
Carbon dioxide [Partial pressure] in Arterial blood |
|
34714-6
|
INR in Blood by Coagulation assay |
|
3377-9
|
Barbiturates [Presence] in Urine |
|
8061-4
|
Nuclear Ab [Presence] in Serum |
|
11529-5
|
Surgical pathology study |
|
5196-1
|
Hepatitis B virus surface Ag [Presence] in Serum by Immunoassay |
|
49136-5
|
Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma |
|
14959-1
|
Microalbumin/Creatinine [Mass ratio] in Urine |
|
48346-1
|
HIV 1+O+2 Ab [Units/volume] in Serum or Plasma |
|
3349-8
|
Amphetamines [Presence] in Urine |
|
17856-6
|
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
|
11253-2
|
Tacrolimus [Mass/volume] in Blood |
|
33903-6
|
Ketones [Presence] in Urine |
|
883-9
|
ABO group [Type] in Blood |
|
25371-6
|
Cholesterol in VLDL [Moles/volume] in Serum or Plasma |
|
2458-8
|
IgA [Mass/volume] in Serum |
|
22753-8
|
Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma |
|
32215-6
|
Thyroxine (T4) free index in Serum or Plasma |
|
14930-2
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
|
18282-4
|
Cannabinoids [Presence] in Urine by Screen method |
|
744-3
|
Monocytes/100 leukocytes in Blood by Manual count |
|
5195-3
|
Hepatitis B virus surface Ag [Presence] in Serum |
|
1003-3
|
Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
|
769-0
|
Neutrophils.segmented/100 leukocytes in Blood by Manual count |
|
714-6
|
Eosinophils/100 leukocytes in Blood by Manual count |
|
15067-2
|
Follitropin [Units/volume] in Serum or Plasma |
|
14715-7
|
Estradiol (E2) [Moles/volume] in Serum or Plasma |
|
53927-0
|
Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe & target amplification method |
|
60256-5
|
Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe & target amplification method |
|
702-1
|
Anisocytosis [Presence] in Blood by Light microscopy |
|
707-0
|
Basophils/100 leukocytes in Blood by Manual count |
|
19145-2
|
Reference lab test name |
|
29265-6
|
Calcium [Moles/volume] corrected for albumin in Serum or Plasma |
|
5796-8
|
Hyaline casts [#/area] in Urine sediment by Microscopy low power field |
|
5198-7
|
Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay |
|
14866-8
|
Parathyrin.intact [Moles/volume] in Serum or Plasma |
|
2731-8
|
Parathyrin.intact [Mass/volume] in Serum or Plasma |
|
2465-3
|
IgG [Mass/volume] in Serum |
|
53925-4
|
Chlamydia trachomatis rRNA [Presence] in Urethra by Probe & target amplification method |
|
774-0
|
Ovalocytes [Presence] in Blood by Light microscopy |
|
12454-5
|
Urate crystals amorphous [Presence] in Urine sediment by Light microscopy |
|
30341-2
|
Erythrocyte sedimentation rate |
|
798-9
|
Erythrocytes [#/volume] in Urine by Automated count |
|
1250-0
|
Major crossmatch [interpretation] |
|
22634-0
|
Pathology report gross observation |
|
69419-0
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay |
|
56598-6
|
Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay |
|
11572-5
|
Rheumatoid factor [Units/volume] in Serum |
|
19080-1
|
Choriogonadotropin [Units/volume] in Serum or Plasma |
|
18998-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility] |
|
43304-5
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
10331-7
|
Rh [Type] in Blood |
|
43305-2
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
10701-1
|
Ova+Parasites identified in Stool by Concentration |
|
13362-9
|
Collection duration of Urine |
|
11125-2
|
Platelet morphology finding [Identifier] in Blood |
|
15180-3
|
Hypochromia [Presence] in Blood by Automated count |
|
12258-0
|
Epithelial cells.squamous [Presence] in Urine sediment by Microscopy high power field |
|
22633-2
|
Pathology report site of origin |
|
2472-9
|
IgM [Mass/volume] in Serum |
|
31208-2
|
Specimen source [Identifier] of Unspecified specimen |
|
18928-2
|
Gentamicin [Susceptibility] |
|
14807-2
|
Lead [Moles/volume] in Blood |
|
3255-7
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay |
|
3184-9
|
Activated clotting time in Blood by Coagulation assay |
|
19139-5
|
Pathologist name |
|
6462-6
|
Bacteria identified in Wound by Culture |
|
10501-5
|
Lutropin [Units/volume] in Serum or Plasma |
|
19244-3
|
Character of Urine |
|
19659-2
|
Phencyclidine [Presence] in Urine by Screen method |
|
14928-6
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
|
624-7
|
Bacteria identified in Sputum by Respiratory culture |
|
634-6
|
Bacteria identified in Unspecified specimen by Aerobe culture |
|
50387-0
|
Chlamydia trachomatis rRNA [Presence] in Cervix by Probe & target amplification method |
|
50388-8
|
Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe & target amplification method |
|
35691-5
|
XXX microorganism DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
51656-7
|
Hepatitis C virus Ab Signal/Cutoff [Ratio] in Body fluid |
|
4679-7
|
Reticulocytes/100 erythrocytes in Blood |
|
22635-7
|
Pathology report microscopic observation Other stain |
|
59826-8
|
Creatinine [Moles/volume] in Blood |
|
15150-6
|
Anisocytosis [Presence] in Blood by Automated count |
|
14338-8
|
Prealbumin [Mass/volume] in Serum or Plasma |
|
15198-5
|
Macrocytes [Presence] in Blood by Automated count |
|
33051-4
|
Erythrocytes [Presence] in Urine |
|
6299-2
|
Urea nitrogen [Mass/volume] in Blood |
|
70204-3
|
Cholesterol non HDL [Moles/volume] in Serum or Plasma |
|
2842-3
|
Prolactin [Mass/volume] in Serum or Plasma |
|
6598-7
|
Troponin T.cardiac [Mass/volume] in Serum or Plasma |
|
2888-6
|
Protein [Mass/volume] in Urine |
|
3393-6
|
Benzoylecgonine [Presence] in Urine |
|
9842-6
|
Casts [#/area] in Urine sediment by Microscopy low power field |
|
2069-3
|
Chloride [Moles/volume] in Blood |
|
5334-8
|
Rubella virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
20569-0
|
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma |
|
42931-6
|
Chlamydia trachomatis rRNA [Presence] in Urine by Probe & target amplification method |
|
15199-3
|
Microcytes [Presence] in Blood by Automated count |
|
20629-2
|
Levofloxacin [Susceptibility] |
|
3397-7
|
Cocaine [Presence] in Urine |
|
779-9
|
Poikilocytosis [Presence] in Blood by Light microscopy |
|
35591-7
|
Creatinine renal clearance predicted by Cockcroft-Gault formula |
|
32356-8
|
Yeast [Presence] in Urine sediment by Light microscopy |
|
18878-9
|
Cefazolin [Susceptibility] |
|
740-1
|
Metamyelocytes/100 leukocytes in Blood by Manual count |
|
12851-2
|
Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis |
|
31147-2
|
Reagin Ab [Titer] in Serum by RPR |
|
25428-4
|
Glucose [Presence] in Urine by Test strip |
|
1960-4
|
Bicarbonate [Moles/volume] in Arterial blood |
|
2111-3
|
Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
|
2039-6
|
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
|
2862-1
|
Albumin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2871-2
|
Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2865-4
|
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2868-8
|
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
18906-8
|
Ciprofloxacin [Susceptibility] |
|
14890-8
|
Progesterone [Moles/volume] in Serum or Plasma |
|
13950-1
|
Hepatitis A virus IgM Ab [Presence] in Serum by Immunoassay |
|
28541-1
|
Metamyelocytes/100 leukocytes in Blood |
|
3936-2
|
Phencyclidine [Presence] in Urine |
|
48159-8
|
Hepatitis C virus Ab Signal/Cutoff [Ratio] in Serum or Plasma by Immunoassay |
|
2874-6
|
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
31201-7
|
HIV 1+2 Ab [Presence] in Serum by Immunoassay |
|
14914-6
|
Testosterone Free [Moles/volume] in Serum or Plasma |
|
58413-6
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Automated count |
|
36903-3
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by Probe & target amplification method |
|
580-1
|
Fungus identified in Unspecified specimen by Culture |
|
2692-2
|
Osmolality of Serum or Plasma |
|
18865-6
|
Ampicillin+Sulbactam [Susceptibility] |
|
18864-9
|
Ampicillin [Susceptibility] |
|
14771-0
|
Fasting glucose [Moles/volume] in Serum or Plasma |
|
635-3
|
Bacteria identified in Unspecified specimen by Anaerobe culture |
|
547-0
|
Streptococcus.beta-hemolytic [Presence] in Unspecified specimen by Organism specific culture |
|
5194-6
|
Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
18955-5
|
Nitrofurantoin [Susceptibility] |
|
18481-2
|
Streptococcus pyogenes Ag [Presence] in Throat |
|
14754-6
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
|
12235-8
|
Microscopic observation [Identifier] in Urine sediment by Light microscopy |
|
7791-7
|
Dacrocytes [Presence] in Blood by Light microscopy |
|
14675-3
|
Cortisol [Moles/volume] in Serum or Plasma |
|
14611-8
|
Nuclear Ab pattern [interpretation] in Serum |
|
8099-4
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma |
|
5048-4
|
Nuclear Ab [Titer] in Serum by Immunofluorescence |
|
2524-7
|
Lactate [Moles/volume] in Serum or Plasma |
|
763-3
|
Neutrophils.band form [#/volume] in Blood by Manual count |
|
30522-7
|
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method |
|
11156-7
|
Leukocyte morphology finding [Identifier] in Blood |
|
19000-9
|
Vancomycin [Susceptibility] |
|
2335-8
|
Hemoglobin.gastrointestinal [Presence] in Stool |
|
6824-7
|
Color of Body fluid |
|
24113-3
|
Hepatitis B virus core IgM Ab [Presence] in Serum by Immunoassay |
|
14578-9
|
ABO group [Type] in Blood from Blood product unit |
|
14907-0
|
Rh [Type] in Blood from Blood product unit |
|
14877-5
|
Phenytoin [Moles/volume] in Serum or Plasma |
|
14698-5
|
Digoxin [Moles/volume] in Serum or Plasma |
|
13965-9
|
Homocysteine [Moles/volume] in Serum or Plasma |
|
55593-8
|
Creatinine [Moles/volume] in unspecified time Urine |
|
18893-8
|
Ceftazidime [Susceptibility] |
|
18970-4
|
Piperacillin+Tazobactam [Susceptibility] |
|
54218-3
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood |
|
800-3
|
Schistocytes [Presence] in Blood by Light microscopy |
|
21198-7
|
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
|
14719-9
|
Ethanol [Moles/volume] in Serum or Plasma |
|
22763-7
|
Ammonia [Mass/volume] in Plasma |
|
16362-6
|
Ammonia [Moles/volume] in Plasma |
|
3426-4
|
Tetrahydrocannabinol [Presence] in Urine |
|
26487-9
|
Monocytes/100 leukocytes in Body fluid |
|
11031-2
|
Lymphocytes/100 leukocytes in Body fluid |
|
749-2
|
Myelocytes/100 leukocytes in Blood by Manual count |
|
18932-4
|
Imipenem [Susceptibility] |
|
18943-1
|
Meropenem [Susceptibility] |
|
32673-6
|
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma |
|
22322-2
|
Hepatitis B virus surface Ab [Presence] in Serum |
|
13655-6
|
Leukocytes [Presence] in Stool by Light microscopy |
|
8123-2
|
CD3+CD4+ (T4 helper) cells/100 cells in Blood |
|
26498-6
|
Myelocytes/100 leukocytes in Blood |
|
19162-7
|
Varicella zoster virus IgG Ab [Presence] in Serum |
|
18879-7
|
Cefepime [Susceptibility] |
|
5783-6
|
Unidentified crystals [Presence] in Urine sediment by Light microscopy |
|
39797-6
|
Vancomycin [Moles/volume] in Serum or Plasma --trough |
|
4092-3
|
Vancomycin [Mass/volume] in Serum or Plasma --trough |
|
8124-0
|
CD3 cells/100 cells in Blood |
|
31017-7
|
Tissue transglutaminase IgA Ab [Units/volume] in Serum |
|
3150-0
|
Inhaled oxygen concentration |
|
1834-1
|
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
|
3167-4
|
Volume of 24 hour Urine |
|
18895-3
|
Ceftriaxone [Susceptibility] |
|
1925-7
|
Base excess in Arterial blood |
|
1990-1
|
Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma |
|
47094-8
|
Calciferol (Vit D2) [Moles/volume] in Serum or Plasma |
|
14796-7
|
Insulin [Moles/volume] in Serum or Plasma |
|
18993-6
|
Tetracycline [Susceptibility] |
|
17790-7
|
Leukocytes Left Shift [Presence] in Blood by Automated count |
|
13955-0
|
Hepatitis C virus Ab [Presence] in Serum by Immunoassay |
|
18996-9
|
Tobramycin [Susceptibility] |
|
8101-8
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Blood |
|
13451-0
|
Creatinine dialysis fluid clearance |
|
1305-2
|
D Ag [Presence] in Blood |
|
5130-0
|
DNA double strand Ab [Units/volume] in Serum |
|
14581-3
|
Acetaminophen [Moles/volume] in Serum or Plasma |
|
14895-7
|
Protein Fractions [interpretation] in Serum or Plasma by Immunofixation |
|
18886-2
|
Cefotaxime [Susceptibility] |
|
35492-8
|
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] by Probe & target amplification method |
|
14946-8
|
Valproate [Moles/volume] in Serum or Plasma |
|
34148-7
|
Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum |
|
18969-6
|
Piperacillin [Susceptibility] |
|
2955-3
|
Sodium [Moles/volume] in Urine |
|
10381-2
|
Target cells [Presence] in Blood by Light microscopy |
|
18860-7
|
Amikacin [Susceptibility] |
|
12238-2
|
Neutrophils/100 leukocytes in Body fluid by Manual count |
|
8098-6
|
Thyroglobulin Ab [Units/volume] in Serum or Plasma |
|
3773-9
|
Methadone [Presence] in Urine |
|
26452-3
|
Eosinophils/100 leukocytes in Body fluid |
|
18961-3
|
Oxacillin [Susceptibility] |
|
10352-3
|
Bacteria identified in Genital specimen by Aerobe culture |
|
4073-3
|
Tricyclic antidepressants [Presence] in Serum or Plasma |
|
1006-6
|
Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells |
|
31160-5
|
Polymorphonuclear cells/100 leukocytes in Blood by Manual count |
|
7790-9
|
Burr cells [Presence] in Blood by Light microscopy |
|
543-9
|
Mycobacterium sp identified in Unspecified specimen by Organism specific culture |
|
20564-1
|
Oxygen saturation in Blood |
|
8122-4
|
CD3 cells [#/volume] in Blood |
|
21667-1
|
F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
584-3
|
Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture |
|
10334-1
|
Cancer Ag 125 [Units/volume] in Serum or Plasma |
|
34713-8
|
Clostridium difficile toxin A+B [Presence] in Stool |
|
26510-8
|
Neutrophils.band form/100 leukocytes in Body fluid |
|
8246-1
|
Amorphous sediment [Presence] in Urine sediment by Light microscopy |
|
18919-1
|
Erythromycin [Susceptibility] |
|
26455-6
|
Erythrocytes [#/volume] in Body fluid |
|
4485-9
|
Complement C3 [Mass/volume] in Serum or Plasma |
|
4498-2
|
Complement C4 [Mass/volume] in Serum or Plasma |
|
57845-0
|
Leukocytes [#/volume] in Body fluid by Automated count |
|
5176-3
|
Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay |
|
16128-1
|
Hepatitis C virus Ab [Presence] in Serum |
|
14135-8
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood |
|
7918-6
|
HIV 1+2 Ab [Presence] in Serum |
|
19312-8
|
Tricyclic antidepressants [Presence] in Urine by Screen method |
|
18908-4
|
Clindamycin [Susceptibility] |
|
14684-5
|
Creatinine [Moles/time] in 24 hour Urine |
|
13518-6
|
Lymphocytes Variant/100 leukocytes in Body fluid by Manual count |
|
12179-8
|
Basophils/100 leukocytes in Body fluid by Manual count |
|
6864-3
|
Hemoglobin S [Presence] in Blood by Solubility test |
|
49563-0
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit = 0.01 ng/mL |
|
33255-1
|
Cell Fractions/Differential [interpretation] in Blood |
|
2708-6
|
Oxygen saturation in Arterial blood |
|
5209-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
18964-7
|
Penicillin [Susceptibility] |
|
18868-0
|
Aztreonam [Susceptibility] |
|
1863-0
|
Anion gap 4 in Serum or Plasma |
|
19994-3
|
Oxygen/Inspired gas setting [Volume Fraction] Ventilator |
|
21654-9
|
CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
14909-6
|
Salicylates [Moles/volume] in Serum or Plasma |
|
70200-1
|
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma |
|
19113-0
|
IgE [Units/volume] in Serum |
|
12232-5
|
Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
14688-6
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
|
625-4
|
Bacteria identified in Stool by Culture |
|
24475-6
|
F2 gene p.G20210A [Presence] in Blood or Tissue by Molecular genetics method |
|
30318-0
|
Base deficit in Blood |
|
743-5
|
Monocytes [#/volume] in Blood by Manual count |
|
5569-9
|
Acetone [Presence] in Urine |
|
3520-4
|
Cyclosporine [Mass/volume] in Blood |
|
32693-4
|
Lactate [Moles/volume] in Blood |
|
48065-7
|
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma |
|
2110-5
|
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma |
|
13952-7
|
Hepatitis B virus core Ab [Presence] in Serum by Immunoassay |
|
610-6
|
Bacteria identified in Body fluid by Aerobe culture |
|
5403-1
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
803-7
|
Toxic granules [Presence] in Blood by Light microscopy |
|
33358-3
|
Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis |
|
65633-0
|
Hepatitis B virus surface Ag [Presence] in Serum by Confirmatory method |
|
10524-7
|
Microscopic observation [Identifier] in Cervix by Cyto stain |
|
29247-4
|
Sirolimus [Mass/volume] in Blood |
|
739-3
|
Metamyelocytes [#/volume] in Blood by Manual count |
|
2889-4
|
Protein [Mass/time] in 24 hour Urine |
|
18887-0
|
Cefotetan [Susceptibility] |
|
10335-8
|
Color of Cerebral spinal fluid |
|
39778-6
|
Iron/Iron binding capacity.total [Molar ratio] in Serum or Plasma |
|
30089-7
|
Transitional cells [#/area] in Urine sediment by Microscopy high power field |
|
20761-3
|
Clostridium difficile [Presence] in Stool by Agglutination |
|
2828-2
|
Potassium [Moles/volume] in Urine |
|
29891-9
|
Helicobacter pylori [Presence] in Stomach by urea breath test |
|
19107-2
|
Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
2639-3
|
Myoglobin [Mass/volume] in Serum or Plasma |
|
5028-6
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe |
|
1922-4
|
Base deficit in Arterial blood |
|
48058-2
|
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay |
|
35365-6
|
Vitamin D+Metabolites [Mass/volume] in Serum or Plasma |
|
772-4
|
Nucleated erythrocytes [#/volume] in Blood by Manual count |
|
806-0
|
Leukocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
14566-4
|
Calcitriol [Moles/volume] in Serum or Plasma |
|
3181-5
|
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay |
|
3182-3
|
Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay |
|
4546-8
|
Hemoglobin A/Hemoglobin.total in Blood |
|
49541-6
|
Fasting status [Presence] - Reported |
|
4576-5
|
Hemoglobin F/Hemoglobin.total in Blood |
|
2890-2
|
Protein/Creatinine [Mass ratio] in Urine |
|
33935-8
|
Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum |
|
16935-9
|
Hepatitis B virus surface Ab [Units/volume] in Serum |
|
5193-8
|
Hepatitis B virus surface Ab [Units/volume] in Serum by Immunoassay |
|
20399-2
|
Nuclear Ab pattern.nucleolar [Titer] in Serum |
|
25145-4
|
Bacteria [Presence] in Urine sediment by Light microscopy |
|
24467-3
|
CD3+CD4+ (T4 helper) cells [#/volume] in Blood |
|
33762-6
|
Natriuretic peptide.B prohormone [Mass/volume] in Serum or Plasma |
|
48066-5
|
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma |
|
4625-0
|
Hemoglobin S/Hemoglobin.total in Blood |
|
2746-6
|
pH of Venous blood |
|
3376-1
|
Barbiturates [Presence] in Serum, Plasma or Blood |
|
546-2
|
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture |
|
21484-1
|
Mother's race |
|
2021-4
|
Carbon dioxide [Partial pressure] in Venous blood |
|
30446-9
|
Myelocytes [#/volume] in Blood |
|
748-4
|
Myelocytes [#/volume] in Blood by Manual count |
|
17898-8
|
Bacteria identified in Throat by Aerobe culture |
|
673-4
|
Microscopic observation [Identifier] in Unspecified specimen by Ova & Parasite Preparation |
|
5064-1
|
Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay |
|
32998-7
|
Tissue transglutaminase IgG Ab [Units/volume] in Serum |
|
56537-4
|
Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay |
|
11011-4
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
12841-3
|
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
|
11006-4
|
Borrelia burgdorferi Ab [Presence] in Serum |
|
2880-3
|
Protein [Mass/volume] in Cerebral spinal fluid |
|
33944-0
|
Immunoglobulin light chains.lambda.free [Mass/volume] in Serum or Plasma |
|
3389-4
|
Benzodiazepines [Presence] in Serum or Plasma |
|
5206-8
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
19066-0
|
Blood bank comment |
|
48803-1
|
Neural tube defect risk in Fetus |
|
4563-3
|
Hemoglobin C/Hemoglobin.total in Blood |
|
49049-0
|
Collection time of Unspecified specimen |
|
13503-8
|
Borrelia burgdorferi Ab.IgM band pattern [interpretation] in Serum by Immunoblot (IB) |
|
14725-6
|
[Type] of Body fluid |
|
21299-3
|
Gestational age method |
|
4545-0
|
Hematocrit [Volume Fraction] of Blood by Centrifugation |
|
10362-2
|
Endomysium IgA Ab [Presence] in Serum |
|
18862-3
|
Amoxicillin+Clavulanate [Susceptibility] |
|
14744-7
|
Glucose [Moles/volume] in Cerebral spinal fluid |
|
18965-4
|
Penicillin G [Susceptibility] |
|
9587-7
|
Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot (IB) |
|
18390-5
|
Opiates [Presence] in Urine by Confirmatory method |
|
10886-0
|
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
|
14196-0
|
Reticulocytes [#/volume] in Blood |
|
2695-5
|
Osmolality of Urine |
|
42481-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe & signal amplification method |
|
13951-9
|
Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
|
13502-0
|
Borrelia burgdorferi Ab.IgG band pattern [interpretation] in Serum by Immunoblot (IB) |
|
11090-8
|
Smith extractable nuclear Ab [Units/volume] in Serum |
|
606-4
|
Bacteria identified in Cerebral spinal fluid by Culture |
|
6561-5
|
Treponema pallidum IgG Ab [Presence] in Serum |
|
47238-1
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay |
|
18185-9
|
Gestational age |
|
9597-6
|
Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
31418-7
|
Heterophile Ab [Presence] in Serum |
|
17792-3
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
|
11004-9
|
Tricyclic antidepressants [Presence] in Urine |
|
17791-5
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
|
9593-5
|
Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9590-1
|
Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9594-3
|
Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9589-3
|
Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9591-9
|
Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9592-7
|
Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9599-2
|
Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot (IB) |
|
9598-4
|
Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot (IB) |
|
9595-0
|
Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
9596-8
|
Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
47000-5
|
Candida sp rRNA [Presence] in Vaginal fluid by DNA probe |
|
9588-5
|
Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot (IB) |
|
44357-2
|
Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
6410-5
|
Gardnerella vaginalis rRNA [Presence] in Genital specimen by DNA probe |
|
6568-0
|
Trichomonas vaginalis rRNA [Presence] in Genital specimen by DNA probe |
|
14564-9
|
Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen |
|
2164-2
|
Creatinine renal clearance in 24 hour |
|
43371-4
|
Salmonella sp/Shigella sp identified in Stool by Organism specific culture |
|
6331-3
|
Campylobacter sp identified in Stool by Organism specific culture |
|
21262-1
|
Escherichia coli shiga-like [Presence] in Stool by Immunoassay |
|
29374-6
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
|
9335-1
|
Appearance of Body fluid |
|
19157-7
|
Tube number of Cerebral spinal fluid |
|
29463-7
|
Body weight |
|
36916-5
|
Immunoglobulin light chains.kappa.free [Mass/volume] in Serum |
|
15189-4
|
Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda [Mass ratio] in Serum |
|
70209-2
|
Haptoglobin [Moles/volume] in Serum or Plasma |
|
15120-9
|
Ethanol [Moles/volume] in Blood |
|
19993-5
|
Oxygen/Inspired gas Inhaled gas by Gas dilution.rebreath |
|
6420-4
|
Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay |
|
14565-6
|
Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen |
|
17842-6
|
Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
|
32515-9
|
CD3+CD4+ (T4 helper) cells [#/volume] in Unspecified specimen |
|
7886-5
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum |
|
5159-9
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay |
|
26052-1
|
Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field |
|
7885-7
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum |
|
5157-3
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay |
|
33768-3
|
Leukocyte clumps [#/volume] in Urine by Automated count |
|
23811-3
|
Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma |
|
3013-0
|
Thyroglobulin [Mass/volume] in Serum or Plasma |
|
6206-7
|
Peanut IgE Ab [Units/volume] in Serum |
|
2756-5
|
pH of Urine |
|
2484-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
|
2118-8
|
Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
|
18974-6
|
Rifampin [Susceptibility] |
|
12710-0
|
Hemoglobin pattern [interpretation] in Blood |
|
34705-4
|
Carbon dioxide [Partial pressure] adjusted to patients actual temperature in Blood |
|
19254-2
|
Oxygen [Partial pressure] adjusted to patients actual temperature in Blood |
|
4993-2
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by DNA probe |
|
1977-8
|
Bilirubin [Presence] in Urine |
|
44877-9
|
Insulin dependent diabetes mellitus [Presence] |
|
23641-4
|
Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
14563-1
|
Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen |
|
20447-9
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
5244-9
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
15064-9
|
Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
|
19550-3
|
Methadone [Presence] in Urine by Screen method |
|
49090-4
|
Trisomy 21 risk based on maternal age in Fetus |
|
21026-0
|
Pathologist interpretation of Blood tests |
|
62292-8
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
|
2761-5
|
Phenylketones [Presence] in Blood |
|
3779-6
|
Methamphetamine [Presence] in Urine |
|
35663-4
|
Protein [Mass/volume] in unspecified time Urine |
|
20506-2
|
Specimen drawn from |
|
19057-9
|
ABO & Rh group [Type] in Blood from newborn |
|
626-2
|
Bacteria identified in Throat by Culture |
|
13532-7
|
Xanthochromia [Presence] of Cerebral spinal fluid |
|
34660-1
|
Hemoglobin A2/Hemoglobin.total in Blood by Chromatography column |
|
26454-9
|
Erythrocytes [#/volume] in Cerebral spinal fluid |
|
10333-3
|
Appearance of Cerebral spinal fluid |
|
5822-2
|
Yeast [#/area] in Urine sediment by Microscopy high power field |
|
49092-0
|
Second trimester quad maternal screen [interpretation] in Serum or Plasma Narrative |
|
6276-0
|
Wheat IgE Ab [Units/volume] in Serum |
|
6248-9
|
Soybean IgE Ab [Units/volume] in Serum |
|
75882-1
|
Lupus anticoagulant three screening tests W Reflex [interpretation] |
|
6095-4
|
American house dust mite IgE Ab [Units/volume] in Serum |
|
25160-3
|
Granular casts [Presence] in Urine sediment by Light microscopy |
|
33804-6
|
RBC casts [Presence] in Urine sediment by Light microscopy |
|
703-9
|
Basophilic stippling [Presence] in Blood by Light microscopy |
|
6020-2
|
Alternaria alternata IgE Ab [Units/volume] in Serum |
|
20496-6
|
Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
|
29541-0
|
HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe & target amplification method |
|
6584-7
|
Virus identified in Unspecified specimen by Culture |
|
19343-3
|
Amphetamine [Presence] in Urine by Screen method |
|
13964-2
|
Methylmalonate [Moles/volume] in Serum or Plasma |
|
802-9
|
Spherocytes [Presence] in Blood by Light microscopy |
|
10704-5
|
Ova+Parasites identified in Stool by Light microscopy |
|
5185-4
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum by Immunoassay |
|
46269-7
|
25-Hydroxycalciferol [Moles/volume] in Serum or Plasma |
|
7258-7
|
Cow milk IgE Ab [Units/volume] in Serum |
|
19554-5
|
Methamphetamine [Presence] in Urine by Screen method |
|
10328-3
|
Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
2705-2
|
Oxygen [Partial pressure] in Venous blood |
|
43994-3
|
Trisomy 18 risk in Fetus |
|
14334-7
|
Lithium [Moles/volume] in Serum or Plasma |
|
41477-1
|
Bacterial sialidase [Presence] in Unspecified specimen |
|
33254-4
|
pH of Arterial blood adjusted to patients actual temperature |
|
21612-7
|
Age - Reported |
|
14639-9
|
Carbamazepine [Moles/volume] in Serum or Plasma |
|
43995-0
|
Trisomy 21 risk in Fetus |
|
5124-3
|
Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
10366-3
|
Cotinine [Mass/volume] in Urine |
|
6096-2
|
European house dust mite IgE Ab [Units/volume] in Serum |
|
26473-9
|
Leukocytes other/100 leukocytes in Body fluid |
|
24108-3
|
Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
|
5859-4
|
Herpes simplex virus identified in Unspecified specimen by Organism specific culture |
|
5774-5
|
Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy |
|
49121-7
|
Erythrocyte inclusion bodies [Identifier] in Blood |
|
13967-5
|
Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
|
3095-7
|
Urea nitrogen [Mass/volume] in Urine |
|
6025-1
|
Aspergillus fumigatus IgE Ab [Units/volume] in Serum |
|
21264-7
|
Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma |
|
25836-8
|
HIV 1 RNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method |
|
46640-9
|
Secondary diagnosis RFC |
|
42216-2
|
Reference lab name [Identifier] |
|
48391-7
|
Carbon dioxide, total [Moles/volume] in Venous blood by calculation |
|
35678-2
|
Sodium [Moles/volume] in unspecified time Urine |
|
10459-6
|
Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
|
5793-5
|
Granular casts [#/area] in Urine sediment by Microscopy low power field |
|
6099-6
|
Dog epithelium IgE Ab [Units/volume] in Serum |
|
34701-3
|
Platelet Ab.heparin induced [Presence] in Serum |
|
20495-8
|
Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
|
1761-6
|
Aldolase [Enzymatic activity/volume] in Serum or Plasma |
|
8248-7
|
Spermatozoa [Presence] in Urine sediment by Light microscopy |
|
2078-4
|
Chloride [Moles/volume] in Urine |
|
31374-2
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum |
|
30083-0
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
47223-3
|
Trisomy 18 risk based on maternal age in Fetus |
|
14633-2
|
C peptide [Moles/volume] in Serum or Plasma |
|
23883-2
|
Inhibin A [Mass/volume] in Serum |
|
34468-9
|
Clostridium difficile toxin A+B [Presence] in Stool by Immunoassay |
|
2881-1
|
Protein [Mass/volume] in Body fluid |
|
3243-3
|
Thrombin time |
|
19270-8
|
Barbiturates [Presence] in Urine by Screen method |
|
15432-8
|
Testosterone Free/Testosterone.total in Serum or Plasma |
|
26466-3
|
Leukocytes [#/volume] in Body fluid |
|
21440-3
|
Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by DNA probe |
|
14874-2
|
Phenobarbital [Moles/volume] in Serum or Plasma |
|
10835-7
|
Lipoprotein a [Mass/volume] in Serum or Plasma |
|
22330-5
|
Hepatitis D virus Ab [Units/volume] in Serum |
|
38526-0
|
Number of specimens tested of Stool |
|
40752-8
|
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay |
|
6833-8
|
Cat dander IgE Ab [Units/volume] in Serum |
|
5813-1
|
Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy |
|
6189-5
|
White Oak IgE Ab [Units/volume] in Serum |
|
6075-6
|
Cladosporium herbarum IgE Ab [Units/volume] in Serum |
|
14314-9
|
Benzoylecgonine [Presence] in Urine by Screen method |
|
5332-2
|
Rubella virus Ab [Presence] in Serum by Latex agglutination |
|
12248-1
|
Epithelial cells.renal [Presence] in Urine sediment by Light microscopy |
|
5892-5
|
Protein S [Units/volume] in Platelet poor plasma by Coagulation assay |
|
4552-6
|
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis |
|
22314-9
|
Hepatitis A virus IgM Ab [Presence] in Serum |
|
46154-1
|
Trichomonas vaginalis rRNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
6357-8
|
Chlamydia trachomatis DNA [Presence] in Urine by Probe & target amplification method |
|
36904-1
|
Inhibin A [Multiple of the median] adjusted in Serum |
|
5862-8
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immunoassay |
|
45371-2
|
Multiple pregancy |
|
2742-5
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
|
32764-3
|
Clue cells [Presence] in Unspecified specimen by Wet preparation |
|
42247-7
|
Hemoglobin pattern [interpretation] in Blood by HPLC Narrative |
|
11153-4
|
Hematocrit [Volume Fraction] of Body fluid |
|
6875-9
|
Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
|
32166-1
|
Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma |
|
6741-3
|
Erythrocytes [#/volume] in Body fluid by Manual count |
|
7900-4
|
Helicobacter pylori Ab [Units/volume] in Serum |
|
6087-1
|
Corn IgE Ab [Units/volume] in Serum |
|
14955-9
|
Zinc [Moles/volume] in Serum or Plasma |
|
11259-9
|
Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe & target amplification method |
|
38180-6
|
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
3299-5
|
Acetaminophen [Presence] in Urine |
|
14731-4
|
Folate [Moles/volume] in Red Blood Cells |
|
5370-2
|
Streptolysin O Ab [Units/volume] in Serum |
|
6041-8
|
Bermuda grass IgE Ab [Units/volume] in Serum |
|
53962-7
|
Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma |
|
17859-0
|
Helicobacter pylori IgG Ab [Presence] in Serum by Immunoassay |
|
6212-5
|
Penicillium notatum IgE Ab [Units/volume] in Serum |
|
22496-4
|
Rubella virus Ab [Presence] in Serum |
|
49050-8
|
Microscopic observation [Identifier] in Endocervical brush by Cyto stain |
|
21190-4
|
Chlamydia trachomatis DNA [Presence] in Cervix by Probe and target amplification method |
|
30457-6
|
Nonhematic cells/100 leukocytes in Body fluid |
|
34985-2
|
Unidentified cells/100 leukocytes in Body fluid |
|
7966-5
|
Mumps virus IgG Ab [Units/volume] in Serum |
|
20512-0
|
Turbidity [Presence] of Cerebral spinal fluid |
|
32198-4
|
Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe |
|
6085-5
|
Common Ragweed IgE Ab [Units/volume] in Serum |
|
6110-1
|
English Plantain IgE Ab [Units/volume] in Serum |
|
6303-2
|
dRVVT LA screen |
|
27811-9
|
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method |
|
47213-4
|
Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma |
|
70201-9
|
Cholesterol in IDL [Moles/volume] in Serum or Plasma |
|
70202-7
|
Cholesterol in IDL+Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma |
|
70203-5
|
Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma |
|
49062-3
|
Lipid risk factors [Finding] |
|
32046-5
|
Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma |
|
26760-9
|
Cannabinoids [Units/volume] in Urine |
|
13183-9
|
White Elm IgG Ab [Units/volume] in Serum |
|
29967-7
|
Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence |
|
1795-4
|
Amylase [Enzymatic activity/volume] in Body fluid |
|
1871-3
|
Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
|
33716-2
|
Non-gynecological cytology method study |
|
14586-2
|
Aldosterone [Moles/volume] in Serum or Plasma |
|
34574-4
|
Pathology report final diagnosis |
|
45353-0
|
Date of analysis of unspecified specimen |
|
2064-4
|
Ceruloplasmin [Mass/volume] in Serum or Plasma |
|
792-2
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
29771-3
|
Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method |
|
30170-5
|
American Cockroach IgE Ab [Units/volume] in Serum |
|
14627-4
|
Bicarbonate [Moles/volume] in Venous blood |
|
31204-1
|
Hepatitis B virus core IgM Ab [Presence] in Serum |
|
14626-6
|
Beta-2-Microglobulin [Moles/volume] in Serum |
|
1952-1
|
Beta-2-Microglobulin [Mass/volume] in Serum |
|
13514-5
|
Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative |
|
24012-7
|
HIV 1 Ag [Presence] in Serum |
|
5222-5
|
HIV 1 Ag [Presence] in Serum by Immunoassay |
|
13953-5
|
Hepatitis B virus e Ab [Presence] in Serum by Immunoassay |
|
14745-4
|
Glucose [Moles/volume] in Body fluid |
|
15205-8
|
Rheumatoid factor [Units/volume] in Serum by Nephlometry |
|
29770-5
|
Karyotype [Identifier] in Blood or Tissue Nominal |
|
709-6
|
Blasts/100 leukocytes in Blood by Manual count |
|
20444-6
|
Herpes simplex virus 1+2 DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
19153-6
|
Volume of unspecified time Urine |
|
3209-4
|
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
7155-5
|
Boxelder IgE Ab [Units/volume] in Serum |
|
5866-9
|
Influenza virus B Ag [Presence] in Unspecified specimen by Immunoassay |
|
13590-5
|
Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
|
47528-5
|
Cytology report of Cervical or vaginal smear or scraping Cyto stain |
|
6106-9
|
Egg white IgE Ab [Units/volume] in Serum |
|
2006-5
|
Cancer Ag 125 [Presence] in Serum or Plasma |
|
655-1
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun modified |
|
3854-7
|
Nicotine [Mass/volume] in Urine |
|
16131-5
|
Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
13954-3
|
Hepatitis B virus e Ag [Presence] in Serum by Immunoassay |
|
26446-5
|
Blasts/100 leukocytes in Blood |
|
7792-5
|
Dohle body [Presence] in Blood by Light microscopy |
|
2529-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid |
|
41399-7
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
22674-6
|
Transferrin [Moles/volume] in Serum or Plasma |
|
3034-6
|
Transferrin [Mass/volume] in Serum or Plasma |
|
10900-9
|
Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
|
3284-7
|
Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay |
|
3414-0
|
Buprenorphine [Presence] in Urine |
|
20404-0
|
Fibronectin.fetal [Presence] in Vaginal fluid |
|
10998-3
|
Oxycodone [Presence] in Urine |
|
10976-9
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
|
14674-6
|
Corticotropin [Moles/volume] in Plasma |
|
13046-8
|
Lymphocytes Variant/100 leukocytes in Blood |
|
5351-2
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
6412-1
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay |
|
2614-6
|
Methemoglobin/Hemoglobin.total in Blood |
|
5353-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
2915-7
|
Renin [Enzymatic activity/volume] in Plasma |
|
27416-7
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum |
|
6565-6
|
Trichomonas vaginalis [Identifier] in Genital specimen by Wet preparation |
|
21003-9
|
Fungus identified in Unspecified specimen by Fungus stain |
|
5639-0
|
Ethanol [Presence] in Blood |
|
6182-0
|
Mucor racemosus IgE Ab [Units/volume] in Serum |
|
3297-9
|
Acetaminophen [Presence] in Serum or Plasma |
|
5177-1
|
Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay |
|
13516-0
|
Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
4023-8
|
Salicylates [Presence] in Serum or Plasma |
|
15054-0
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
|
30243-0
|
Choriogonadotropin.intact [Units/volume] in Serum or Plasma |
|
14995-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
4547-6
|
Hemoglobin A1/Hemoglobin.total in Blood |
|
51724-3
|
Cefuroxime [Susceptibility] |
|
15061-5
|
Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
|
6152-3
|
Johnson grass IgE Ab [Units/volume] in Serum |
|
6252-1
|
Stemphylium botryosum IgE Ab [Units/volume] in Serum |
|
32286-7
|
Hepatitis C virus genotype [Identifier] in Serum or Plasma by Probe & target amplification method |
|
17948-1
|
Fungus # 3 identified in Unspecified specimen by Culture |
|
5199-5
|
Hepatitis C virus Ab [Presence] in Serum by Immunoblot (IB) |
|
17947-3
|
Fungus # 2 identified in Unspecified specimen by Culture |
|
17949-9
|
Fungus # 4 identified in Unspecified specimen by Culture |
|
42637-9
|
Natriuretic peptide B [Mass/volume] in Blood |
|
9327-8
|
Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay |
|
14679-5
|
Cortisol [Moles/volume] in Serum or Plasma --morning specimen |
|
14569-8
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
|
14604-3
|
Blood group antibodies present [Identifier] in Serum or Plasma from Blood product unit |
|
20513-8
|
Turbidity [Presence] of Body fluid |
|
48035-0
|
Hemoglobin [Presence] in Cerebral spinal fluid |
|
1825-9
|
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
|
5213-4
|
Heterophile Ab [Presence] in Serum by Latex agglutination |
|
13440-3
|
Immunofixation [interpretation] for Urine |
|
6039-2
|
Beef IgE Ab [Units/volume] in Serum |
|
18929-0
|
Gentamicin.high potency [Susceptibility] |
|
2004-0
|
Calcium [Moles/volume] in Urine |
|
6034-3
|
Bahia grass IgE Ab [Units/volume] in Serum |
|
5358-7
|
Smooth muscle Ab [Titer] in Serum by Immunofluorescence |
|
5388-4
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum by Immunoassay |
|
27948-9
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
9439-1
|
Casts [#/area] in Urine sediment by Microscopy high power field |
|
2745-8
|
pH of Capillary blood |
|
33022-5
|
Carbon dioxide [Partial pressure] in Capillary blood by Transcutaneous CO2 monitor |
|
13438-7
|
Protein Fractions [interpretation] in Urine by Electrophoresis |
|
8117-4
|
CD19 cells/100 cells in Blood |
|
38527-8
|
Number of specimens received of Stool |
|
70216-7
|
Salicylates [Moles/volume] in Serum or Plasma by Screen method |
|
22747-0
|
Gentamicin [Moles/volume] in Serum or Plasma --trough |
|
3665-7
|
Gentamicin [Mass/volume] in Serum or Plasma --trough |
|
14753-8
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
13527-7
|
Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
32765-0
|
Yeast [Presence] in Unspecified specimen by Wet preparation |
|
20563-3
|
Carboxyhemoglobin/Hemoglobin.total in Blood |
|
51597-3
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
14836-1
|
Methotrexate [Moles/volume] in Serum or Plasma |
|
6924-5
|
Gliadin IgA Ab [Units/volume] in Serum |
|
18983-7
|
Streptomycin.high potency [Susceptibility] |
|
14765-2
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
|
5876-8
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
56490-6
|
Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method --2nd specimen |
|
56491-4
|
Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method --3rd specimen |
|
14759-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
|
8665-2
|
Date last menstrual period |
|
27819-2
|
Protein C actual/normal in Platelet poor plasma by Coagulation assay |
|
5076-5
|
Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay |
|
26486-1
|
Monocytes/100 leukocytes in Cerebral spinal fluid |
|
1884-6
|
Apolipoprotein B [Mass/volume] in Serum or Plasma |
|
29953-7
|
Nuclear Ab [Titer] in Serum |
|
7291-8
|
Whole Egg IgE Ab [Units/volume] in Serum |
|
22745-4
|
Ethanol [Moles/volume] in Urine |
|
11545-1
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain |
|
6473-3
|
Microscopic observation [Identifier] in Tissue by Trichrome stain |
|
20460-2
|
Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
14757-9
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
21033-6
|
Yeast.budding [Presence] in Urine sediment |
|
19941-4
|
Oxygen gas flow Oxygen delivery system |
|
6073-1
|
Chocolate IgE Ab [Units/volume] in Serum |
|
12208-5
|
Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
12278-8
|
Neutrophils.band form/100 leukocytes in Cerebral spinal fluid by Manual count |
|
14637-3
|
Calcium [Moles/time] in 24 hour Urine |
|
13519-4
|
Basophils/100 leukocytes in Cerebral spinal fluid by Manual count |
|
3160-9
|
Volume of Semen |
|
38908-0
|
Poikilocytosis [Presence] in Blood by Automated count |
|
13517-8
|
Lymphocytes Variant/100 leukocytes in Cerebral spinal fluid by Manual count |
|
41016-7
|
Bilirubin.total [Moles/volume] in Urine by Test strip |
|
13529-3
|
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
|
10329-1
|
Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
|
26472-1
|
Leukocytes other/100 leukocytes in Cerebral spinal fluid |
|
13508-7
|
Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
|
11135-1
|
Appearance of Spun Cerebral spinal fluid |
|
13525-1
|
Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
|
14764-5
|
Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
|
28008-1
|
Cytomegalovirus DNA [Presence] in Blood by Probe & signal amplification method |
|
6244-8
|
Sheep Sorrel IgE Ab [Units/volume] in Serum |
|
6219-0
|
Pork IgE Ab [Units/volume] in Serum |
|
11050-2
|
Immunoglobulin light chains.kappa [Mass/volume] in Serum |
|
783-1
|
Promyelocytes/100 leukocytes in Blood by Manual count |
|
70207-6
|
Estrogen [Moles/volume] in Serum or Plasma |
|
11064-3
|
Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
|
6273-7
|
Walnut IgE Ab [Units/volume] in Serum |
|
14638-1
|
Calculus analysis [interpretation] in Stone |
|
8191-9
|
Cocaine [Presence] in Serum or Plasma by Screen method |
|
13068-2
|
Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence |
|
8149-7
|
Amphetamines [Presence] in Serum or Plasma by Screen method |
|
6153-1
|
Kentucky blue grass IgE Ab [Units/volume] in Serum |
|
14756-1
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
|
26524-9
|
Promyelocytes/100 leukocytes in Blood |
|
8234-7
|
Phencyclidine [Presence] in Meconium by Screen method |
|
11065-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
|
19141-1
|
Propoxyphene [Presence] in Urine |
|
19415-9
|
Tetrahydrocannabinol [Presence] in Urine by Screen method |
|
35741-8
|
Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit = 0.01 ng/mL |
|
6265-3
|
Timothy IgE Ab [Units/volume] in Serum |
|
6233-1
|
Rough Pigweed IgE Ab [Units/volume] in Serum |
|
39796-8
|
Vancomycin [Moles/volume] in Serum or Plasma --peak |
|
4090-7
|
Vancomycin [Mass/volume] in Serum or Plasma --peak |
|
2026-3
|
Carbon dioxide, total [Moles/volume] in Arterial blood |
|
2714-4
|
Fractional oxyhemoglobin in Arterial blood |
|
22131-7
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
|
5404-9
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
14905-4
|
Retinol [Moles/volume] in Serum or Plasma |
|
33718-8
|
Cytology report of Tissue fine needle aspirate Cyto stain |
|
8112-5
|
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood |
|
19774-9
|
Cytology study comment Cervical or vaginal smear or scraping Cyto stain |
|
19128-8
|
Bacteria identified in Catheter tip by Culture |
|
6281-0
|
White mulberry IgE Ab [Units/volume] in Serum |
|
24013-5
|
HIV 1 RNA [interpretation] in Serum |
|
17780-8
|
Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
|
13169-8
|
Immunoelectrophoresis [interpretation] for Serum or Plasma |
|
15210-8
|
Thyroglobulin Ab [Presence] in Serum |
|
4532-8
|
Complement total hemolytic CH50 [Units/volume] in Serum or Plasma |
|
2748-2
|
pH of Body fluid |
|
26513-2
|
Neutrophils/100 leukocytes in Body fluid |
|
8130-7
|
CD45 (Lymphs) cells/100 cells in Blood |
|
11276-3
|
Tubular cells [Presence] in Urine sediment by Light microscopy |
|
25458-1
|
Lamotrigine [Moles/volume] in Serum or Plasma |
|
29641-8
|
Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence |
|
5034-4
|
Streptococcus agalactiae rRNA [Presence] in Unspecified specimen by DNA probe |
|
773-2
|
Nucleated erythrocytes/100 erythrocytes in Blood by Manual count |
|
35383-9
|
Galactomannan Ag [Units/volume] in Serum or Plasma |
|
22587-0
|
Treponema pallidum Ab [Presence] in Serum |
|
6178-8
|
Mountain Juniper IgE Ab [Units/volume] in Serum |
|
11266-4
|
Streptococcus agalactiae Ag [Presence] in Unspecified specimen |
|
22746-2
|
Gentamicin [Moles/volume] in Serum or Plasma --peak |
|
3663-2
|
Gentamicin [Mass/volume] in Serum or Plasma --peak |
|
1927-3
|
Base excess in Venous blood |
|
5247-2
|
Mitochondria Ab [Titer] in Serum by Immunofluorescence |
|
5126-8
|
Cytomegalovirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
48378-4
|
Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free [Mass Ratio] in Serum |
|
15069-8
|
Fructosamine [Moles/volume] in Serum or Plasma |
|
15218-1
|
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
|
28005-7
|
MTHFR gene p.C677T [Presence] in Blood or Tissue by Molecular genetics method |
|
8014-3
|
Rubella virus IgG Ab [Units/volume] in Serum |
|
14912-0
|
Smudge cells/100 leukocytes in Blood by Manual count |
|
12230-9
|
Macrophages/100 leukocytes in Body fluid by Manual count |
|
27038-9
|
Endomysium IgA Ab [Titer] in Serum by Immunofluorescence |
|
20573-2
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation |
|
6246-3
|
Shrimp IgE Ab [Units/volume] in Serum |
|
42176-8
|
1,3 beta glucan [Mass/volume] in Serum |
|
19075-1
|
Cells Counted Total [#] in Cerebral spinal fluid |
|
33910-1
|
Rheumatoid factor [Presence] in Serum |
|
9822-8
|
Bacteria identified in Dialysis fluid by Culture |
|
931-6
|
Blood product source [Type] |
|
32140-6
|
Hemoglobin F [Presence] in Blood by Kleihauer-Betke method |
|
53982-5
|
Centromere protein B Ab [Units/volume] in Serum |
|
51775-5
|
Chromatin Ab [Units/volume] in Serum or Plasma |
|
19295-5
|
Opiates [Presence] in Urine by Screen method |
|
24011-9
|
Hepatitis C virus Ab band pattern [interpretation] in Serum by Immunoblot (IB) |
|
5187-0
|
Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay |
|
2963-7
|
Somatotropin [Mass/volume] in Serum or Plasma |
|
13530-1
|
Nucleated erythrocytes [#/volume] in Body fluid by Manual count |
|
6082-2
|
Codfish IgE Ab [Units/volume] in Serum |
|
6156-4
|
Goosefoot IgE Ab [Units/volume] in Serum |
|
6186-1
|
Nettle IgE Ab [Units/volume] in Serum |
|
11565-9
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum |
|
30376-8
|
Blasts [#/volume] in Blood |
|
35676-6
|
Chloride [Moles/volume] in unspecified time Urine |
|
32637-1
|
Urease [Presence] in Tissue |
|
46248-1
|
Borrelia burgdorferi IgG & IgM [interpretation] in Serum by Immunoassay |
|
1721-0
|
Adenosine triphosphate [Mass/volume] in Blood |
|
9780-8
|
Spermatozoa [#/volume] in Semen |
|
6002-0
|
Platelet factor 4 [Units/volume] in Platelet poor plasma |
|
6014-5
|
von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Aggregation |
|
20475-0
|
Cytomegalovirus IgG Ab [interpretation] in Serum |
|
33248-6
|
Diabetes status [Identifier] |
|
33006-8
|
Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method |
|
22415-4
|
Mumps virus IgG Ab [Presence] in Serum |
|
6476-6
|
Mumps virus IgG Ab [Presence] in Serum by Immunoassay |
|
49053-2
|
History of neural tube defect Narrative |
|
21024-5
|
Pathologist interpretation of Cerebral spinal fluid tests |
|
13522-8
|
Blasts/100 leukocytes in Body fluid by Manual count |
|
5274-6
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay |
|
5273-8
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay |
|
13992-3
|
Albumin/Protein.total in Urine by Electrophoresis |
|
5393-4
|
Treponema pallidum Ab [Presence] in Serum by Immunofluorescence |
|
13990-7
|
Alpha 1 globulin/Protein.total in Urine by Electrophoresis |
|
801-1
|
Sickle cells [Presence] in Blood by Light microscopy |
|
14582-1
|
Acetone [Moles/volume] in Serum or Plasma |
|
7407-0
|
White Hickory IgE Ab [Units/volume] in Serum |
|
46420-6
|
Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field |
|
30471-7
|
Levetiracetam [Mass/volume] in Serum or Plasma |
|
40750-2
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence |
|
6019-4
|
Almond IgE Ab [Units/volume] in Serum |
|
41874-9
|
White Birch IgE Ab [Units/volume] in Serum |
|
2466-1
|
IgG subclass 1 [Mass/volume] in Serum |
|
6968-2
|
Proteinase 3 Ab [Units/volume] in Serum |
|
42768-2
|
HIV 1 & 2 Ab [interpretation] in Serum Narrative |
|
16126-5
|
Helicobacter pylori IgG Ab [Presence] in Serum |
|
11258-1
|
Hepatitis B virus DNA [Units/volume] in Serum |
|
667-6
|
Microscopic observation [Identifier] in Unspecified specimen by KOH preparation |
|
1747-5
|
Albumin [Mass/volume] in Body fluid |
|
9586-9
|
Borrelia burgdorferi Ab [interpretation] in Serum |
|
681-7
|
Microscopic observation [Identifier] in Unspecified specimen by Wright stain |
|
6942-7
|
Albumin [Mass/volume] in Urine by Electrophoresis |
|
6969-0
|
Myeloperoxidase Ab [Units/volume] in Serum |
|
6183-8
|
Mugwort IgE Ab [Units/volume] in Serum |
|
3719-2
|
Lithium [Mass/volume] in Serum or Plasma |
|
2469-5
|
IgG subclass 4 [Mass/volume] in Serum |
|
2467-9
|
IgG subclass 2 [Mass/volume] in Serum |
|
2468-7
|
IgG subclass 3 [Mass/volume] in Serum |
|
32146-3
|
Platelets Large [Presence] in Blood by Light microscopy |
|
14277-8
|
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
|
14278-6
|
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
|
12180-6
|
Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
48344-6
|
Kaolin activated time in Platelet poor plasma |
|
28637-7
|
Base deficit in Venous cord blood |
|
18500-9
|
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
|
13987-3
|
Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
13989-9
|
Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
78012-2
|
Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay |
|
34661-9
|
Actin IgG Ab [Units/volume] in Serum or Plasma |
|
41274-2
|
Alpha-1-Fetoprotein interpretation [interpretation] in Serum or Plasma |
|
33719-6
|
Flow cytometry study |
|
5158-1
|
Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence |
|
24476-4
|
F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
14929-4
|
Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
|
25700-6
|
Immunofixation [interpretation] for Serum or Plasma |
|
14915-3
|
Theophylline [Moles/volume] in Serum or Plasma |
|
11878-6
|
Number of fetuses by US |
|
14676-1
|
Cortisol Free [Moles/time] in 24 hour Urine |
|
21020-3
|
Bacteria identified in Unspecified specimen by Anaerobe+Aerobe culture |
|
19108-0
|
Histoplasma capsulatum Ag [Presence] in Serum |
|
44525-4
|
Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay |
|
2115-4
|
Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma |
|
32167-9
|
Clarity of Urine |
|
26518-1
|
Polymorphonuclear cells/100 leukocytes in Body fluid |
|
19076-9
|
Cells Counted Total [#] in Unspecified specimen |
|
33673-5
|
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate |
|
32133-1
|
Lactate [Moles/volume] in Plasma venous |
|
12286-1
|
Drugs identified in Urine by Screen method |
|
6263-8
|
American Sycamore IgE Ab [Units/volume] in Serum |
|
5095-5
|
Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID) |
|
8187-7
|
Benzoylecgonine [Presence] in Meconium |
|
13994-9
|
Beta globulin/Protein.total in Urine by Electrophoresis |
|
26523-1
|
Promyelocytes [#/volume] in Blood |
|
6098-8
|
Dog dander IgE Ab [Units/volume] in Serum |
|
22310-7
|
Helicobacter pylori Ab [Presence] in Serum |
|
20124-4
|
Ventilation mode [Identifier] Ventilator |
|
6107-7
|
Egg yolk IgE Ab [Units/volume] in Serum |
|
6604-3
|
Influenza virus identified in Unspecified specimen by Organism specific culture |
|
28647-6
|
pH of Venous cord blood |
|
6800-7
|
Spermatozoa Motile/100 spermatozoa in Semen |
|
6718-1
|
Cashew Nut IgE Ab [Units/volume] in Serum |
|
5181-3
|
Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
1961-2
|
Bicarbonate [Moles/volume] in Capillary blood |
|
28646-8
|
pH of Arterial cord blood |
|
11051-0
|
Immunoglobulin light chains.lambda [Mass/volume] in Serum |
|
32032-5
|
Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay |
|
25362-5
|
Calcium [Moles/volume] in 24 hour Urine |
|
7793-3
|
Howell-Jolly bodies [Presence] in Blood by Light microscopy |
|
35668-3
|
Gentamicin [Mass/volume] in Serum or Plasma |
|
47109-4
|
Gentamicin [Moles/volume] in Serum or Plasma |
|
11274-8
|
Elliptocytes [Presence] in Blood by Light microscopy |
|
46995-7
|
HLA-DP+DQ+DR (class II) Ab in Serum |
|
46994-0
|
HLA-A+B+C (class I) Ab in Serum |
|
6208-3
|
Pecan or Hickory Nut IgE Ab [Units/volume] in Serum |
|
17851-7
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum |
|
43180-9
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoassay |
|
30166-3
|
Thyroid stimulating immunoglobulins actual/normal in Serum |
|
9631-3
|
Viscosity of Semen |
|
10585-8
|
Round cells [#/volume] in Semen |
|
33217-1
|
Spermatozoa Agglutinated [Presence] in Semen |
|
5218-3
|
Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) |
|
27822-6
|
Protein S actual/normal in Platelet poor plasma by Coagulation assay |
|
17793-1
|
Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
|
17850-9
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum |
|
51916-5
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoassay |
|
31844-4
|
Hepatitis B virus e Ag [Presence] in Serum |
|
20450-3
|
Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma |
|
48343-8
|
Hemoglobin.other/Hemoglobin.total in Blood |
|
5160-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence |
|
29615-2
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
21032-8
|
Thrombin time [interpretation] in Blood |
|
5791-9
|
Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field |
|
20423-0
|
Beta lactamase organism identified in Isolate |
|
8146-3
|
Amphetamines [Presence] in Meconium by Screen method |
|
20991-6
|
Antithrombin [interpretation] in Platelet poor plasma |
|
33720-4
|
Blood bank consult |
|
2483-6
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
|
34712-0
|
Clostridium difficile [Presence] in Stool |
|
33594-3
|
Platelet factor 4 [Presence] in Platelet poor plasma |
|
8169-5
|
Tetrahydrocannabinol [Presence] in Meconium by Screen method |
|
22663-9
|
Estrone (E1) [Moles/volume] in Serum or Plasma |
|
17849-1
|
Reticulocytes/100 erythrocytes in Blood by Automated count |
|
8216-4
|
Opiates [Presence] in Meconium by Screen method |
|
27816-8
|
von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunologic method |
|
8116-6
|
CD19 cells [#/volume] in Blood |
|
7798-2
|
Smudge cells [Presence] in Blood by Light microscopy |
|
9795-6
|
Composition in Stone |
|
5390-0
|
Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay |
|
32218-0
|
Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay |
|
46266-3
|
Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay |
|
20479-2
|
Measles virus IgG Ab [Presence] in Serum |
|
35275-7
|
Measles virus IgG Ab [Presence] in Serum by Immunoassay |
|
5781-0
|
Crystals [type] in Synovial fluid by Light microscopy |
|
26043-0
|
HLA-B27 [Presence] by Probe & target amplification method |
|
16136-4
|
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
|
44449-7
|
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
19296-3
|
Opiates tested for in Urine by Screen method Nominal |
|
14115-0
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
|
14761-1
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
|
5290-2
|
Reagin Ab [Presence] in Cerebral spinal fluid by VDRL |
|
5817-2
|
Urate crystals [Presence] in Urine sediment by Light microscopy |
|
46267-1
|
Proteinase 3 Ab [Units/volume] in Serum by Immunoassay |
|
2270-7
|
Fat [Presence] in Stool |
|
6278-6
|
White Ash IgE Ab [Units/volume] in Serum |
|
7369-2
|
Perennial rye grass IgE Ab [Units/volume] in Serum |
|
8091-1
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
|
41222-1
|
Yeast [Presence] in Body fluid by Light microscopy |
|
38505-4
|
Thyroglobulin recovery in Serum or Plasma |
|
16135-6
|
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
|
44448-9
|
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
6076-4
|
Clam IgE Ab [Units/volume] in Serum |
|
593-4
|
Legionella sp identified in Unspecified specimen by Organism specific culture |
|
33437-5
|
Oxygen [Partial pressure] in Capillary blood by Transcutaneous O2 monitor |
|
48683-7
|
Streptococcus agalactiae DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
20574-0
|
Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation |
|
49539-0
|
Cytomegalovirus IgM Ab [Presence] in Serum by Immunofluorescence |
|
33721-2
|
Bone marrow Pathology biopsy report |
|
5127-6
|
Cytomegalovirus IgM Ab [Titer] in Serum by Immunofluorescence |
|
33773-3
|
Karyotype [Identifier] in Amniotic fluid Nominal |
|
49051-6
|
Gestational age in weeks |
|
7789-1
|
Acanthocytes [Presence] in Blood by Light microscopy |
|
8338-6
|
Body weight Measured --ante partum |
|
5117-7
|
Cryoglobulin [Presence] in Serum |
|
2752-4
|
pH of Semen |
|
15359-3
|
dRVVT actual/?normal (normalized LA screen) |
|
2077-6
|
Chloride [Moles/volume] in Sweat |
|
41499-5
|
Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay |
|
3141-9
|
Body weight Measured |
|
5348-8
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
15761-0
|
Sweetgum IgE Ab RAST class in Serum |
|
2615-3
|
Methemoglobin/Hemoglobin.total in Arterial blood |
|
5053-4
|
Aspergillus sp Ab [Titer] in Serum by Complement fixation |
|
33247-8
|
Weight of Sweat |
|
5183-9
|
Hepatitis A virus Ab [Units/volume] in Serum by Immunoassay |
|
29893-5
|
HIV 1 Ab [Presence] in Serum by Immunoassay |
|
20465-1
|
Choriogonadotropin [Multiple of the median] in Serum or Plasma |
|
20466-9
|
Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma |
|
38404-0
|
CFTR gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative |
|
27923-2
|
Ubiquinone 10 [Mass/volume] in Serum or Plasma |
|
26512-4
|
Neutrophils/100 leukocytes in Cerebral spinal fluid |
|
48039-2
|
Fibronectin.fetal [Presence] in Unspecified specimen |
|
14665-4
|
Copper [Moles/volume] in Serum or Plasma |
|
5880-0
|
Rotavirus Ag [Presence] in Stool by Immunoassay |
|
15083-9
|
Normetanephrine [Moles/time] in 24 hour Urine |
|
1924-0
|
Base deficit in Venous blood |
|
49573-9
|
HIV genotype [Susceptibility] in Isolate by Genotype method Narrative |
|
15191-0
|
Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
|
5356-1
|
Smith extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
23761-0
|
Neutrophils/100 leukocytes in Blood by Manual count |
|
5297-7
|
Rheumatoid factor [Presence] in Serum by Latex agglutination |
|
5301-7
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
9783-2
|
Ehrlichia chaffeensis IgG Ab [Titer] in Serum |
|
25156-1
|
Eosinophils [Presence] in Urine sediment by Light microscopy |
|
19839-0
|
Breath rate spontaneous --on ventilator |
|
13539-2
|
Phosphate [Moles/volume] in Urine |
|
13988-1
|
Beta globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
4621-9
|
Hemoglobin S [Presence] in Blood |
|
26471-3
|
Leukocytes other/100 leukocytes in Blood |
|
46082-4
|
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay |
|
46083-2
|
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay |
|
2357-2
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
28645-0
|
Carbon dioxide [Partial pressure] in Venous cord blood |
|
39786-9
|
Pyridoxine [Moles/volume] in Serum or Plasma |
|
5809-9
|
Reducing substances [Presence] in Urine |
|
28649-2
|
Oxygen [Partial pressure] in Venous cord blood |
|
6825-4
|
Crystals [type] in Body fluid by Light microscopy |
|
20458-6
|
Rubella virus IgG Ab [interpretation] in Serum |
|
27818-4
|
Protein C actual/normal in Platelet poor plasma by Chromogenic method |
|
7691-9
|
Scallop IgE Ab [Units/volume] in Serum |
|
20474-3
|
Bacteria identified in Tissue by Biopsy culture |
|
28641-9
|
Bicarbonate [Moles/volume] in Venous cord blood |
|
12234-1
|
Mesothelial cells/100 leukocytes in Body fluid by Manual count |
|
23877-4
|
Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence |
|
28644-3
|
Carbon dioxide [Partial pressure] in Arterial cord blood |
|
2956-1
|
Sodium [Moles/time] in 24 hour Urine |
|
28648-4
|
Oxygen [Partial pressure] in Arterial cord blood |
|
14252-1
|
Smooth muscle Ab [Presence] in Serum |
|
21108-6
|
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum |
|
44447-1
|
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum by Immunoassay |
|
9784-0
|
Ehrlichia chaffeensis IgM Ab [Titer] in Serum |
|
49701-6
|
pH of Blood adjusted to patients actual temperature |
|
6891-6
|
Testosterone.bioavailable/Testosterone.total in Serum or Plasma |
|
11261-5
|
Bacteria identified in Vaginal fluid by Aerobe culture |
|
23878-2
|
Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence |
|
2112-1
|
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine |
|
49047-4
|
Globulin [Mass/volume] in Urine by Electrophoresis |
|
28640-1
|
Bicarbonate [Moles/volume] in Arterial cord blood |
|
32319-6
|
Glucose [Moles/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
|
25459-9
|
Lead [Moles/volume] in Serum or Plasma |
|
57804-7
|
Number of occult blood specimens recommended by testing kit protocol [#] in Stool |
|
32207-3
|
Platelet distribution width [Entitic volume] in Blood by Automated count |
|
25386-4
|
Creatinine [Moles/volume] in Body fluid |
|
3174-0
|
Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
33393-0
|
Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field |
|
9490-4
|
Aspergillus flavus Ab [Presence] in Serum |
|
26447-3
|
Blasts/100 leukocytes in Cerebral spinal fluid |
|
8095-2
|
Smooth muscle Ab [Titer] in Serum |
|
14712-4
|
Epinephrine [Moles/time] in 24 hour Urine |
|
6136-6
|
Hazelnut IgE Ab [Units/volume] in Serum |
|
9660-2
|
HIV 1 gp160 Ab [Presence] in Serum by Immunoblot (IB) |
|
2873-8
|
Gamma globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis |
|
9668-5
|
HIV 1 p55 Ab [Presence] in Serum by Immunoblot (IB) |
|
9667-7
|
HIV 1 p51 Ab [Presence] in Serum by Immunoblot (IB) |
|
24469-9
|
Hemoglobin XXX/Hemoglobin.total in Blood by Electrophoresis |
|
771-6
|
Nucleated erythrocytes [#/volume] in Blood by Automated count |
|
9664-4
|
HIV 1 p24 Ab [Presence] in Serum by Immunoblot (IB) |
|
9661-0
|
HIV 1 gp120 Ab [Presence] in Serum by Immunoblot (IB) |
|
9666-9
|
HIV 1 p31 Ab [Presence] in Serum by Immunoblot (IB) |
|
11070-0
|
Microscopic observation [Identifier] in Urine by Cyto stain |
|
14650-6
|
Citrate [Moles/time] in 24 hour Urine |
|
14603-5
|
Androstenedione [Moles/volume] in Serum or Plasma |
|
13993-1
|
Alpha 2 globulin/Protein.total in Urine by Electrophoresis |
|
5785-1
|
Eosinophils [#/area] in Urine sediment by Microscopy high power field |
|
13995-6
|
Gamma globulin/Protein.total in Urine by Electrophoresis |
|
14854-4
|
Norepinephrine [Moles/time] in 24 hour Urine |
|
5354-6
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
85991-8
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum |
|
85992-6
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
1869-7
|
Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
|
33332-8
|
Linezolid [Susceptibility] by Gradient strip |
|
5352-0
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
2640-1
|
Myoglobin [Presence] in Urine |
|
2998-3
|
Thiamine [Mass/volume] in Blood |
|
38544-3
|
Spermatozoa [#/volume] in Semen --pre washing |
|
38540-1
|
Spermatozoa Motile/100 spermatozoa in Semen --pre washing |
|
3746-5
|
Meperidine [Presence] in Urine |
|
12195-4
|
Creatinine renal clearance/1.73 sq M in 24 hour |
|
15059-9
|
Dopamine [Moles/time] in 24 hour Urine |
|
11140-1
|
Metanephrine [Moles/time] in 24 hour Urine |
|
28643-5
|
Oxygen saturation in Venous cord blood |
|
5057-5
|
Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation |
|
6092-1
|
Crab IgE Ab [Units/volume] in Serum |
|
13926-1
|
Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
|
2513-0
|
Ketones [Presence] in Serum or Plasma |
|
2518-9
|
Lactate [Moles/volume] in Arterial blood |
|
6007-9
|
Protein C [Units/volume] in Platelet poor plasma by Coagulation assay |
|
14708-2
|
Endomysium Ab [Titer] in Serum |
|
7984-8
|
Parvovirus B19 IgM Ab [Units/volume] in Serum |
|
11039-5
|
C reactive protein [Presence] in Serum or Plasma |
|
32680-1
|
Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field |
|
30340-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum |
|
24115-8
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay |
|
28642-7
|
Oxygen saturation in Arterial cord blood |
|
25489-6
|
Normetanephrine [Moles/volume] in Serum or Plasma |
|
19942-2
|
Oxygen gas flow setting Oxymizer |
|
18319-4
|
Neutrophils.vacuolated [Presence] in Blood by Light microscopy |
|
15530-9
|
Alternaria alternata IgE Ab RAST class in Serum |
|
3256-5
|
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
|
35789-7
|
Daptomycin [Susceptibility] |
|
21365-2
|
Leptin [Mass/volume] in Serum or Plasma |
|
21441-1
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by DNA probe |
|
14956-7
|
Microalbumin [Mass/time] in 24 hour Urine |
|
14935-1
|
Urate [Moles/time] in 24 hour Urine |
|
5863-6
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
34524-9
|
Neutrophils.band form [Presence] in Blood by Automated count |
|
23841-0
|
Choriogonadotropin.beta subunit [Multiple of the median] adjusted in Serum or Plasma |
|
1857-2
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
|
31797-4
|
Cytomegalovirus Ag [Presence] in Unspecified specimen |
|
6379-2
|
Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunoassay |
|
16264-4
|
Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy |
|
49542-4
|
Date and time of pheresis procedure |
|
30339-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum |
|
24114-1
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay |
|
32554-8
|
Thiamine [Moles/volume] in Blood |
|
14316-4
|
Benzodiazepines [Presence] in Urine by Screen method |
|
9796-4
|
Color of Stone |
|
9802-0
|
Size [Entitic volume] of Stone |
|
2428-1
|
Homocysteine [Mass/volume] in Serum or Plasma |
|
35538-8
|
Baker's yeast IgG Ab [Mass/volume] in Serum |
|
48050-9
|
Neutrophils [Presence] in Stool by Wright stain |
|
20593-0
|
CD19 cells/100 cells in Unspecified specimen |
|
25170-2
|
Mercury [Moles/volume] in Blood |
|
2605-4
|
Meat fibers [Presence] in Stool by Light microscopy |
|
730-2
|
Leukocytes other/100 leukocytes in Blood by Manual count |
|
8249-5
|
Transitional cells [Presence] in Urine sediment by Light microscopy |
|
30427-9
|
Macrophages/100 leukocytes in Body fluid |
|
19835-8
|
Breath rate setting Ventilator synchronized intermittent mandatory |
|
27395-3
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum |
|
40913-6
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay |
|
15212-4
|
Lipase [Enzymatic activity/volume] in Body fluid |
|
3507-1
|
Codeine [Presence] in Urine |
|
86024-7
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum |
|
86021-3
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86064-3
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum |
|
86061-9
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86107-0
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum |
|
86108-8
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
4575-7
|
Hemoglobin E/Hemoglobin.total in Blood |
|
30153-1
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum |
|
40926-8
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay |
|
35127-0
|
Hemoglobin A2.prime/Hemoglobin.total in Blood |
|
31156-3
|
Hemoglobin Barts/Hemoglobin.total in Blood |
|
4569-0
|
Hemoglobin D/Hemoglobin.total in Blood |
|
33593-5
|
Hemoglobin G - Coushatta/Hemoglobin.total in Blood |
|
35125-4
|
Hemoglobin Lepore/Hemoglobin.total in Blood |
|
35126-2
|
Hemoglobin O - Arab/Hemoglobin.total in Blood |
|
13986-5
|
Albumin/Protein.total in 24 hour Urine by Electrophoresis |
|
6165-5
|
Lobster IgE Ab [Units/volume] in Serum |
|
21709-1
|
MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
14833-8
|
Metanephrines [Moles/time] in 24 hour Urine |
|
13984-0
|
Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis |
|
38415-6
|
MTHFR gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative |
|
42484-6
|
Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis |
|
10863-9
|
Endomysium IgA Ab [Titer] in Serum |
|
3830-7
|
Morphine [Presence] in Urine |
|
14947-6
|
Vanillylmandelate [Moles/time] in 24 hour Urine |
|
14835-3
|
Methanol [Moles/volume] in Serum or Plasma |
|
13499-9
|
HIV 1 Ab band pattern [interpretation] in Serum by Immunoblot (IB) |
|
49540-8
|
Acid citrate dextrose [Volume] in Blood product unit |
|
5292-8
|
Reagin Ab [Presence] in Serum by VDRL |
|
31102-7
|
Protein S actual/normal in Platelet poor plasma by Chromogenic method |
|
25157-9
|
Epithelial casts [Presence] in Urine sediment by Light microscopy |
|
33333-6
|
Colistin [Susceptibility] by Gradient strip |
|
71790-0
|
Calcium [Moles/volume] in unspecified time Urine |
|
588-4
|
Legionella pneumophila Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
8150-5
|
Amphetamines [Mass/volume] in Urine |
|
40287-5
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post meal |
|
17607-3
|
Volume of Cerebral spinal fluid |
|
43583-4
|
Lipoprotein a [Moles/volume] in Serum or Plasma |
|
52956-0
|
Barbiturates [Moles/volume] in Urine |
|
52955-2
|
Benzodiazepines [Moles/volume] in Urine |
|
9428-4
|
Benzodiazepines [Mass/volume] in Urine |
|
31032-6
|
Baker's yeast IgA Ab [Units/volume] in Serum |
|
47320-7
|
Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay |
|
22086-3
|
Aspergillus niger Ab [Presence] in Serum |
|
6164-8
|
Virginia Live Oak IgE Ab [Units/volume] in Serum |
|
33915-0
|
Anabasine [Mass/volume] in Urine |
|
13358-7
|
Collection time of Semen |
|
25507-5
|
Pregnenolone [Moles/volume] in Serum or Plasma |
|
34519-9
|
HFE gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative |
|
28545-2
|
Mucus [#/area] in Urine sediment by Microscopy low power field |
|
6113-5
|
Gum-Tree IgE Ab [Units/volume] in Serum |
|
27118-9
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum |
|
40905-2
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
12856-1
|
HIV 1 p65 Ab [Presence] in Serum by Immunoblot (IB) |
|
19077-7
|
Cells identified in Body fluid |
|
86080-9
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum |
|
86081-7
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
25296-5
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum |
|
40911-0
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86147-6
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum |
|
86148-4
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86169-0
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum |
|
86166-6
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay |
|
15048-2
|
Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
12187-1
|
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
15049-0
|
Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis |
|
9662-8
|
HIV 1 gp41 Ab [Presence] in Serum by Immunoblot (IB) |
|
85954-6
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum |
|
85955-3
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
26019-0
|
Creatine Kinase.macromolecular type 1/Creatine kinase.total in Serum or Plasma |
|
26020-8
|
Creatine Kinase.macromolecular type 2/Creatine kinase.total in Serum or Plasma |
|
41763-4
|
Rubella virus IgG Ab [Titer] in Serum |
|
42483-8
|
Protein.monoclonal/Protein.total in Urine by Electrophoresis |
|
12859-5
|
HIV 1 p18 Ab [Presence] in Serum by Immunoblot (IB) |
|
6050-9
|
Brazil Nut IgE Ab [Units/volume] in Serum |
|
85977-7
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum |
|
85974-4
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
21619-2
|
APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
14934-4
|
Urate [Moles/volume] in Urine |
|
18267-5
|
CD16+CD56+ cells/100 cells in Blood |
|
48560-7
|
Human papilloma virus genotype [Identifier] in Unspecified specimen by Probe & target amplification method |
|
33536-4
|
Miscellaneous allergen IgE Ab RAST class in Serum |
|
14288-5
|
Carnitine [Moles/volume] in Serum or Plasma |
|
20402-4
|
CD16+CD56+ cells [#/volume] in Blood |
|
2333-3
|
Gastrin [Mass/volume] in Serum or Plasma |
|
11778-8
|
Delivery date Estimated |
|
42810-2
|
Hemoglobin [Entitic mass] in Reticulocytes |
|
5191-2
|
Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay |
|
26458-0
|
Erythrocytes [#/volume] in Synovial fluid |
|
14664-7
|
Color of Synovial fluid |
|
8214-9
|
Opiates [Presence] in Meconium |
|
14286-9
|
Carnitine free (C0) [Moles/volume] in Serum or Plasma |
|
27939-8
|
Collagen crosslinked N-telopeptide [Moles/volume] in Urine |
|
16130-7
|
Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
32766-8
|
Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation |
|
17284-1
|
Mitochondria Ab [Presence] in Serum by Immunofluorescence |
|
16268-5
|
Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy |
|
7905-3
|
Hepatitis B virus surface Ag [Presence] in Serum by Neutralization test |
|
19126-2
|
Bacteria identified in Bone marrow by Aerobe culture |
|
6158-0
|
Latex IgE Ab [Units/volume] in Serum |
|
3282-1
|
aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay |
|
32031-7
|
Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay |
|
6266-1
|
Tomato IgE Ab [Units/volume] in Serum |
|
6009-5
|
Protein C Ag [Units/volume] in Platelet poor plasma by Immunologic method |
|
936-5
|
Blood product unit [Identifier] |
|
9820-2
|
Cryptococcus sp Ag [Titer] in Serum by Latex agglutination |
|
11013-0
|
DNA double strand Ab [Titer] in Serum |
|
31080-5
|
Cannabinoids [Presence] in Meconium by Screen method |
|
5909-7
|
Blood smear finding [Identifier] in Blood by Light microscopy |
|
22296-8
|
Epstein Barr virus nuclear Ab [Presence] in Serum |
|
575-1
|
Fungus identified in Skin by Culture |
|
5820-6
|
WBC casts [#/area] in Urine sediment by Microscopy low power field |
|
2999-1
|
Thiamine [Mass/volume] in Serum or Plasma |
|
35452-2
|
HIV 1 gp40 Ab [Presence] in Serum by Immunoblot (IB) |
|
20449-5
|
Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay |
|
6174-7
|
Milk IgE Ab [Units/volume] in Serum |
|
13047-6
|
Plasma cells/100 leukocytes in Blood |
|
20999-9
|
Cell Fractions/Differential [interpretation] in Body fluid |
|
70206-8
|
Codeine [Moles/volume] in Urine by Confirmatory method |
|
15283-5
|
Silver Birch IgE Ab [Units/volume] in Serum |
|
14622-5
|
Ascorbate [Moles/volume] in Serum or Plasma |
|
40527-4
|
Cocaine [Presence] in Meconium |
|
14573-0
|
5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
|
70208-4
|
Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO |
|
21525-1
|
Sodium [Moles/volume] in 24 hour Urine |
|
14906-2
|
Rh [Type] in Cord blood |
|
20112-9
|
Tidal volume setting Ventilator |
|
8144-8
|
Amphetamines [Presence] in Meconium |
|
6242-2
|
Sesame Seed IgE Ab [Units/volume] in Serum |
|
21023-7
|
Neutrophil cytoplasmic Ab [Titer] in Serum |
|
7983-0
|
Parvovirus B19 IgG Ab [Units/volume] in Serum |
|
30361-0
|
HIV 2 Ab [Presence] in Serum by Immunoassay |
|
781-5
|
Promyelocytes [#/volume] in Blood by Manual count |
|
51892-8
|
ABO group [Type] in Cord blood |
|
42803-7
|
Bacteria identified in Isolate |
|
25631-3
|
Parvovirus B19 IgM Ab [Titer] in Serum |
|
32787-4
|
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum |
|
19429-0
|
Propoxyphene [Presence] in Urine by Screen method |
|
25415-1
|
Folate [Moles/volume] in Blood |
|
70210-0
|
Morphine [Moles/volume] in Urine by Confirmatory method |
|
32585-2
|
Epstein Barr virus DNA [#/volume] (viral load) in Unspecified specimen by Probe & target amplification method |
|
15410-4
|
Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
|
5357-9
|
Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
5036-9
|
Streptococcus pyogenes rRNA [Presence] in Unspecified specimen by DNA probe |
|
40974-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum |
|
40915-1
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
48348-7
|
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
|
30173-9
|
Cortisol Free [Moles/volume] in Urine |
|
9704-8
|
Spermatozoa [Morphology] in Semen |
|
601-5
|
Fungus identified in Blood by Culture |
|
19803-6
|
Specimen site |
|
14881-7
|
Phosphate [Moles/time] in 24 hour Urine |
|
21695-2
|
HFE gene p.C282Y [Presence] in Blood or Tissue by Molecular genetics method |
|
38256-4
|
Cells Counted Total [#] in Body fluid |
|
10587-4
|
Sexual abstinence duration |
|
41479-7
|
BK virus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
21260-5
|
Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence |
|
35270-8
|
Candida sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
14194-5
|
Spermatozoa Progressive/100 spermatozoa in Semen |
|
6190-3
|
Oat IgE Ab [Units/volume] in Serum |
|
6222-4
|
Queen Palm IgE Ab [Units/volume] in Serum |
|
27820-0
|
Protein C Ag actual/normal in Platelet poor plasma by Immunologic method |
|
10579-1
|
Leukocytes [#/volume] in Semen |
|
30247-1
|
Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
30165-5
|
Phosphatidylcholine/Albumin [Mass ratio] in Amniotic fluid |
|
12782-9
|
Protein fractions.oligoclonal bands [interpretation] in Cerebral spinal fluid by Electrophoresis |
|
25361-7
|
Caffeine [Moles/volume] in Serum or Plasma |
|
70217-5
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis |
|
6151-5
|
Italian Cypress IgE Ab [Units/volume] in Serum |
|
5946-9
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
6230-7
|
Rice IgE Ab [Units/volume] in Serum |
|
10525-4
|
Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
|
40692-6
|
Volume of Semen--pre washing |
|
11884-4
|
Gestational age Estimated |
|
19171-8
|
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid |
|
7287-6
|
Dog Fennel IgE Ab [Units/volume] in Serum |
|
44528-8
|
Histoplasma capsulatum M Ab [Presence] in Serum |
|
12227-5
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood |
|
59960-5
|
Propoxyphene [Moles/volume] in Urine |
|
20473-5
|
Polymorphonuclear cells [Presence] in Unspecified specimen by Wright stain |
|
35732-7
|
Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID) |
|
19261-7
|
Amphetamines [Presence] in Urine by Screen method |
|
11235-9
|
Fentanyl [Presence] in Urine |
|
5221-7
|
HIV 1 Ab [Presence] in Serum by Immunoblot (IB) |
|
6109-3
|
White Elm IgE Ab [Units/volume] in Serum |
|
10353-1
|
Bacteria identified in Nose by Aerobe culture |
|
7124-1
|
Bayberry Pollen IgE Ab [Units/volume] in Serum |
|
8251-1
|
Service comment |
|
38996-5
|
Neutrophils [Presence] in Urine by Light microscopy |
|
15197-7
|
Lymphocytes Fissured/100 leukocytes in Blood by Manual count |
|
14207-5
|
Streptococcal DNAse B [Titer] in Serum |
|
44547-8
|
Human papilloma virus DNA [Presence] in Unspecified specimen by Probe & signal amplification method |
|
28543-7
|
Basophils/100 leukocytes in Body fluid |
|
6012-9
|
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
|
7902-0
|
Helicobacter pylori IgG Ab [Units/volume] in Serum |
|
10728-4
|
Trichomonas sp identified in Genital specimen by Organism specific culture |
|
8118-2
|
CD2 cells/100 cells in Blood |
|
38496-6
|
Retinyl palmitate [Mass/volume] in Serum or Plasma |
|
48053-3
|
Turbidity [Presence] of Synovial fluid |
|
33984-6
|
Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method |
|
49839-4
|
Eosinophils [Presence] in Urine sediment by Wright stain |
|
14802-3
|
Isopropanol [Moles/volume] in Serum or Plasma |
|
7816-2
|
Blastomyces dermatitidis Ab [Presence] in Serum |
|
7477-3
|
Mango Pollen IgE Ab [Units/volume] in Serum |
|
36913-2
|
FMR1 gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative |
|
13943-6
|
Fructose [Presence] in Semen |
|
34441-6
|
Spermatozoa [Velocity] in Semen |
|
7110-0
|
Groundsel Tree IgE Ab [Units/volume] in Serum |
|
2464-6
|
IgG [Mass/volume] in Cerebral spinal fluid |
|
6195-2
|
Cocksfoot IgE Ab [Units/volume] in Serum |
|
22752-0
|
Tobramycin [Moles/volume] in Serum or Plasma --trough |
|
4059-2
|
Tobramycin [Mass/volume] in Serum or Plasma --trough |
|
48051-7
|
Erythrocytes [Presence] in Vaginal fluid |
|
19710-3
|
Tramadol [Presence] in Urine by Screen method |
|
22297-6
|
Epstein Barr virus nuclear Ab [Titer] in Serum |
|
27823-4
|
Protein S Ag actual/normal in Platelet poor plasma by Immunologic method |
|
560-3
|
Chlamydia sp identified in Unspecified specimen by Organism specific culture |
|
20427-1
|
Acetylcholine receptor Ab [Moles/volume] in Serum |
|
48038-4
|
Pathologist interpretation of Synovial fluid tests |
|
4551-8
|
Hemoglobin A2/Hemoglobin.total in Blood |
|
47383-5
|
Nuclear Ab [Presence] in Serum by Immunoassay |
|
9557-0
|
CD2 cells [#/volume] in Blood |
|
41476-3
|
Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay |
|
9804-6
|
Weight of Stone |
|
20468-5
|
Thiamine [Moles/volume] in Serum or Plasma |
|
33242-9
|
Fungi.filamentous [Presence] in Urine by Computer assisted method |
|
27821-8
|
Protein S Free Ag actual/normal in Platelet poor plasma by Immunologic method |
|
3175-7
|
Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunologic method |
|
49572-1
|
Second trimester triple maternal screen [interpretation] in Serum or Plasma Narrative |
|
23301-5
|
Mycoplasma sp DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
5256-3
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
|
21760-4
|
FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
16117-4
|
Babesia microti IgG Ab [Titer] in Serum |
|
41475-5
|
Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay |
|
21416-3
|
Neisseria gonorrhoeae DNA [Presence] in Urine by Probe & target amplification method |
|
24119-0
|
Cytomegalovirus IgM Ab [Presence] in Serum by Immunoassay |
|
21582-2
|
Tryptase [Mass/volume] in Serum or Plasma |
|
5255-5
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
13947-7
|
Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
|
14716-5
|
Estriol (E3) [Moles/volume] in Serum or Plasma |
|
24125-7
|
Andorgen free Index in Serum or Plasma |
|
13948-5
|
Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
|
25474-8
|
Metanephrines [Moles/volume] in Serum or Plasma |
|
49580-4
|
HIV 1+2 Ab [Presence] in Unspecified specimen by Rapid test |
|
6021-0
|
Apple IgE Ab [Units/volume] in Serum |
|
26451-5
|
Eosinophils/100 leukocytes in Cerebral spinal fluid |
|
5908-9
|
Platelets Giant [Presence] in Blood by Light microscopy |
|
16118-2
|
Babesia microti IgM Ab [Titer] in Serum |
|
22751-2
|
Tobramycin [Moles/volume] in Serum or Plasma --peak |
|
4057-6
|
Tobramycin [Mass/volume] in Serum or Plasma --peak |
|
30525-0
|
Age |
|
32546-4
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
|
32164-6
|
Cells [#/volume] in Synovial fluid by Manual count |
|
9811-1
|
Chromogranin A [Mass/volume] in Serum or Plasma |
|
10355-6
|
Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
|
15057-3
|
Androstanolone [Moles/volume] in Serum or Plasma |
|
32109-1
|
Phenytoin Free [Moles/volume] in Serum or Plasma |
|
6270-3
|
Tuna IgE Ab [Units/volume] in Serum |
|
7613-3
|
Pistachio IgE Ab [Units/volume] in Serum |
|
14083-0
|
Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
|
18182-6
|
Osmolality of Serum or Plasma by calculation |
|
41279-1
|
Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum |
|
7883-2
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
|
20425-5
|
Cardiolipin IgM Ab [interpretation] in Serum |
|
1746-7
|
Albumin [Mass/volume] in Cerebral spinal fluid |
|
20424-8
|
Cardiolipin IgG Ab [interpretation] in Serum |
|
26479-6
|
Lymphocytes/100 leukocytes in Cerebral spinal fluid |
|
70218-3
|
Triglyceride [Moles/volume] in Blood |
|
609-8
|
Bacteria identified in Eye by Aerobe culture |
|
15643-0
|
Clam IgE Ab RAST class in Serum |
|
14869-2
|
Pathologist review of Blood tests |
|
5814-9
|
Triple phosphate crystals [Presence] in Urine sediment by Light microscopy |
|
30193-7
|
Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
8047-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum |
|
38476-8
|
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma |
|
5834-7
|
Adenovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
6257-0
|
Strawberry IgE Ab [Units/volume] in Serum |
|
28009-9
|
Volume of Urine |
|
13349-6
|
Leukocytes [#/volume] in Stool by Manual count |
|
1992-7
|
Calcitonin [Mass/volume] in Serum or Plasma |
|
26607-2
|
Cystathionine [Moles/volume] in Serum or Plasma |
|
16263-6
|
Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
|
47387-6
|
Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe & target amplification method |
|
698-1
|
Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture |
|
14721-5
|
Ethylene glycol [Moles/volume] in Serum or Plasma |
|
7917-8
|
HIV 1 Ab [Presence] in Serum |
|
17122-3
|
CD19+Kappa+ cells/100 cells in Blood |
|
32786-6
|
Thyroperoxidase Ab [Titer] in Serum or Plasma |
|
25521-6
|
Selenium [Moles/volume] in Serum or Plasma |
|
6209-1
|
Pecan or Hickory Tree IgE Ab [Units/volume] in Serum |
|
4633-4
|
Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method |
|
4821-5
|
HLA-B27 [Presence] |
|
22203-4
|
Clostridium tetani IgG Ab [Units/volume] in Serum |
|
6237-2
|
Salmon IgE Ab [Units/volume] in Serum |
|
48049-1
|
Eosinophils [Presence] in Stool by Wright stain |
|
5202-7
|
Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay |
|
12308-3
|
Hydrocodone [Presence] in Urine |
|
9834-3
|
Hydromorphone [Presence] in Urine |
|
42192-5
|
Nidus [Presence] in Stone |
|
70215-9
|
Oxycodone [Moles/volume] in Urine by Confirmatory method |
|
30437-8
|
Monocytes+Macrophages/100 leukocytes in Body fluid |
|
6035-0
|
Banana IgE Ab [Units/volume] in Serum |
|
19643-6
|
Oxycodone [Presence] in Urine by Confirmatory method |
|
18325-1
|
Oxymorphone [Presence] in Urine by Confirmatory method |
|
47226-6
|
Fetal lung maturity [interpretation] in Amniotic fluid |
|
17395-5
|
Oxymorphone [Mass/volume] in Urine by Confirmatory method |
|
19074-4
|
Carnitine esters [Moles/volume] in Serum or Plasma |
|
12598-9
|
Fat.neutral [Presence] in Stool |
|
17123-1
|
CD19+Lambda+ cells/100 cells in Blood |
|
36922-3
|
TPMT gene mutation analysis in Blood or Tissue by Molecular genetics method Narrative |
|
6194-5
|
Orange IgE Ab [Units/volume] in Serum |
|
5170-6
|
Gliadin IgG Ab [Units/volume] in Serum |
|
26536-3
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
49581-2
|
Reference lab test identifier and name [Identifier] |
|
12210-1
|
Eosinophils/100 leukocytes in Urine sediment by Manual count |
|
7041-7
|
Penicillin G [Susceptibility] by Gradient strip |
|
7042-5
|
Penicillin V [Susceptibility] by Gradient strip |
|
29901-6
|
HTLV 1+2 Ab [Presence] in Serum by Immunoassay |
|
22110-1
|
Bartonella henselae IgG Ab [Titer] in Serum |
|
14251-3
|
Mitochondria M2 IgG Ab [Units/volume] in Serum |
|
26535-5
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin |
|
19593-3
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
|
70197-9
|
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method |
|
59417-6
|
Oxygen saturation in Arterial blood by Pulse oximetry --resting |
|
59412-7
|
Oxygen saturation in Arterial blood by Pulse oximetry --post exercise |
|
6448-5
|
Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
6137-4
|
Hazelnut Pollen IgE Ab [Units/volume] in Serum |
|
5644-0
|
Ethanol [Presence] in Urine |
|
3093-2
|
Urea nitrogen [Mass/volume] in Body fluid |
|
14862-7
|
Oxalate [Moles/time] in 24 hour Urine |
|
1007-4
|
Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
|
59841-7
|
Vendor name [Identifier] in Unspecified specimen |
|
19768-1
|
Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping |
|
5381-9
|
Thyroglobulin Ab [Titer] in Serum by Latex agglutination |
|
808-6
|
Leukocytes [#/volume] in Pleural fluid by Manual count |
|
25726-1
|
Oxcarbazepine [Moles/volume] in Serum or Plasma |
|
25835-0
|
HIV 1 RNA [Presence] in Serum or Plasma by Probe & target amplification method |
|
35051-2
|
Leukocytes other [#/volume] in Body fluid |
|
7893-1
|
Gliadin Ab [Units/volume] in Serum |
|
15015-1
|
Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma |
|
33917-6
|
Nornicotine [Mass/volume] in Urine |
|
15013-6
|
Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma |
|
24378-2
|
Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma |
|
6062-4
|
Casein IgE Ab [Units/volume] in Serum |
|
6220-8
|
Potato IgE Ab [Units/volume] in Serum |
|
6873-4
|
Beta hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
47440-3
|
Hepatitis B virus core Ab [Presence] in Serum from donor |
|
44533-8
|
HIV 1+2 Ab [Presence] in Serum from donor |
|
44538-7
|
HTLV 1+2 Ab [Presence] in Serum from donor |
|
5877-6
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
49846-9
|
Hepatitis C virus Ag [Presence] in Blood or Marrow from donor |
|
9632-1
|
Aspergillus fumigatus Ab [Presence] in Serum |
|
2032-1
|
Carboxyhemoglobin/Hemoglobin.total in Venous blood |
|
71791-8
|
Metanephrines [Moles/volume] in 24 hour Urine |
|
47364-5
|
Hepatitis B virus surface Ag [Presence] in Serum from donor by Immunoassay |
|
13942-8
|
Spermatozoa Motile [Presence] in Semen by Light microscopy |
|
22463-4
|
Reagin Ab [Presence] in Serum from donor |
|
10622-9
|
Spermatozoa Normal/100 spermatozoa in Semen |
|
19088-4
|
Collection of urine specimen start date |
|
47441-1
|
Hepatitis C virus Ab [Presence] in Serum from donor |
|
19089-2
|
Collection of urine specimen start time |
|
15174-6
|
Cryocrit of Serum by Spun Westergren |
|
5000-5
|
Cytomegalovirus DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
19086-8
|
Collection of urine specimen end date |
|
19087-6
|
Collection of urine specimen end time |
|
7558-0
|
Oyster IgE Ab [Units/volume] in Serum |
|
29280-5
|
Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination |
|
43399-5
|
JAK2 gene p.V617F [Presence] in Blood or Tissue by Molecular genetics method |
|
13462-7
|
Apolipoprotein A-I/Apolipoprotein B [Mass ratio] in Serum or Plasma |
|
49295-9
|
Protein Fractions [interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
|
43441-5
|
Bacteria identified in Bronchoalveolar lavage by Aerobe culture |
|
21482-5
|
Protein [Mass/volume] in 24 hour Urine |
|
2597-3
|
Magnesium [Moles/volume] in Red Blood Cells |
|
2669-0
|
Normetanephrine [Mass/volume] in Serum or Plasma |
|
70205-0
|
Clonazepam [Moles/volume] in Serum or Plasma by Screen method |
|
25964-8
|
Normetanephrine [Moles/volume] in 24 hour Urine |
|
13327-2
|
Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
26517-3
|
Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid |
|
3193-0
|
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay |
|
71797-5
|
Protoporphyrin.zinc [Moles/volume] in Red Blood Cells |
|
6367-7
|
Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay |
|
41480-5
|
BK virus DNA [#/volume] (viral load) in Urine by Probe & target amplification method |
|
31788-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid |
|
31843-6
|
Helicobacter pylori Ag [Presence] in Stool |
|
888-8
|
Blood group antibodies identified in Serum or Plasma |
|
25987-9
|
Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
40464-0
|
Drugs identified in Urine by Confirmatory method |
|
13227-4
|
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
|
58787-3
|
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay |
|
32284-2
|
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
19287-2
|
Cannabinoids tested for in Urine by Screen method Nominal |
|
17852-5
|
Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture |
|
6078-0
|
Cockroach IgE Ab [Units/volume] in Serum |
|
15388-2
|
Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture |
|
31036-7
|
Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23871-7
|
Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot (IB) |
|
15917-8
|
Peanut IgE Ab RAST class in Serum |
|
9610-7
|
Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot (IB) |
|
9609-9
|
Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot (IB) |
|
3187-2
|
Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay |
|
43993-5
|
Age at delivery |
|
23860-0
|
Erythrocytes [#/volume] in Body fluid by Automated count |
|
3096-5
|
Urea nitrogen [Mass/time] in 24 hour Urine |
|
6998-9
|
Ceftriaxone [Susceptibility] by Gradient strip |
|
25630-5
|
Parvovirus B19 IgG Ab [Titer] in Serum |
|
15076-3
|
Glucose [Moles/volume] in Urine |
|
19098-3
|
Erythrocytes [Presence] in Amniotic fluid |
|
12229-1
|
Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
|
20446-1
|
Herpes simplex virus IgG Ab [interpretation] in Serum by Immunoassay |
|
6059-0
|
Candida albicans IgE Ab [Units/volume] in Serum |
|
13337-1
|
CD8+HLA-DR+ cells/100 cells in Blood |
|
21112-8
|
Birth date |
|
25435-9
|
Herpes simplex virus IgM Ab [Presence] in Serum |
|
49835-2
|
CD19+IgD+ cells/100 cells in Unspecified specimen |
|
32632-2
|
HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
70239-9
|
Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
|
5096-3
|
Coccidioides immitis Ab [Titer] in Serum by Complement fixation |
|
7774-3
|
Cow whey IgE Ab [Units/volume] in Serum |
|
5052-6
|
Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
29675-6
|
Parvovirus B19 IgG Ab [Presence] in Serum |
|
29660-8
|
Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay |
|
7981-4
|
Parvovirus B19 IgM Ab [Presence] in Serum |
|
40658-7
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay |
|
32147-1
|
Reducing substances [Mass/volume] in Urine |
|
22111-9
|
Bartonella henselae IgM Ab [Titer] in Serum |
|
22362-8
|
HTLV 1+2 Ab [Presence] in Serum |
|
15093-8
|
Protoporphyrin Free [Moles/volume] in Blood |
|
3198-9
|
Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
70240-7
|
Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
|
10386-1
|
Albumin given [Volume] |
|
13589-7
|
Activated protein C resistance [Presence] in Blood by Probe & target amplification method |
|
70214-2
|
Oxazepam [Moles/volume] in Urine by Confirmatory method |
|
8087-9
|
Parietal cell Ab [Units/volume] in Serum |
|
8220-6
|
Opiates [Mass/volume] in Urine |
|
70213-4
|
Nordiazepam [Moles/volume] in Urine by Confirmatory method |
|
23876-6
|
HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe & signal amplification method |
|
42621-3
|
Mycoplasma hominis DNA [Presence] in Blood by Probe & target amplification method |
|
4477-6
|
Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma |
|
6138-2
|
Helminthosporium halodes IgE Ab [Units/volume] in Serum |
|
14703-3
|
Dopamine [Moles/volume] in Serum or Plasma |
|
6037-6
|
Barley IgE Ab [Units/volume] in Serum |
|
7632-3
|
Privet IgE Ab [Units/volume] in Serum |
|
10580-9
|
Liquefaction [Time] in Semen |
|
6460-0
|
Bacteria identified in Sputum by Culture |
|
20416-4
|
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
13941-0
|
Lymphocytes/100 leukocytes in Body fluid by Manual count |
|
47252-2
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe & target amplification method |
|
41487-0
|
Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
|
14116-8
|
IgG synthesis rate [Mass/time] in Serum & CSF by calculation |
|
29539-4
|
HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe & signal amplification method |
|
33630-5
|
HIV protease gene mutations detected [Identifier] in Isolate |
|
21821-4
|
t(9,22)(ABL1,BCR) Translocation [Presence] in Blood or Tissue by Molecular genetics method |
|
33893-9
|
Karyotype [Identifier] in Bone marrow Nominal |
|
20398-4
|
Nuclear Ab Pattern Homogenous [Titer] in Serum |
|
15114-2
|
Arsenic [Moles/volume] in Blood |
|
5234-0
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
16074-7
|
Walnut IgE Ab RAST class in Serum |
|
70212-6
|
Nordiazepam [Moles/volume] in Serum or Plasma by Screen method |
|
15014-4
|
Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma |
|
20431-3
|
Microscopic observation [Identifier] in Unspecified specimen by Smear |
|
49588-7
|
First trimester maternal screen with nuchal translucency [interpretation] Narrative |
|
611-4
|
Bacteria identified in Body fluid by Culture |
|
70211-8
|
Mycophenolate [Moles/volume] in Serum or Plasma |
|
31112-6
|
Reticulocytes/100 erythrocytes in Blood by Manual |
|
25418-5
|
Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
65757-7
|
Pathology biopsy report in Kidney Narrative |
|
65752-8
|
Pathology biopsy report in Liver Narrative |
|
65751-0
|
Pathology biopsy report in Muscle Narrative |
|
65754-4
|
Pathology biopsy report in Skin Narrative |
|
15058-1
|
Dopamine [Moles/volume] in Urine |
|
24521-7
|
Epinephrine [Moles/volume] in Urine |
|
14853-6
|
Norepinephrine [Moles/volume] in Urine |
|
25383-1
|
Cow milk IgE Ab RAST class in Serum |
|
6234-9
|
Saltwort IgE Ab [Units/volume] in Serum |
|
3786-1
|
Methaqualone [Presence] in Urine |
|
11060-1
|
Reducing substances [Presence] in Stool |
|
20469-3
|
Acetone [Presence] in Serum or Plasma by Screen method |
|
50970-3
|
XXX blood group Ab [Titer] in Serum or Plasma by Antihuman globulin |
|
22315-6
|
Hepatitis A virus IgM Ab [Units/volume] in Serum |
|
17713-9
|
Topiramate [Mass/volume] in Serum or Plasma |
|
19125-4
|
Meconium [Presence] in Amniotic fluid |
|
49578-8
|
Aminocaproate cutoff [Mass/volume] in Serum or Plasma |
|
2749-0
|
pH of Gastric fluid |
|
11559-2
|
Fractional oxyhemoglobin in Blood |
|
7415-3
|
Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum |
|
34696-5
|
Collection method [Type] of Semen |
|
7901-2
|
Helicobacter pylori IgA Ab [Units/volume] in Serum |
|
49700-8
|
Metanephrine Free [Moles/volume] in Serum or Plasma |
|
13627-5
|
Erythrocytes [Presence] in Semen by Light microscopy |
|
15192-8
|
Lymphocytes Variant [Presence] in Blood by Automated count |
|
2030-5
|
Carboxyhemoglobin/Hemoglobin.total in Arterial blood |
|
11034-6
|
Acetylcholine receptor binding Ab [Moles/volume] in Serum |
|
5838-8
|
Cytomegalovirus [Presence] in Unspecified specimen by Organism specific culture |
|
24312-1
|
Treponema pallidum Ab [Presence] in Serum by Agglutination |
|
70198-7
|
Acetaminophen [Moles/volume] in Serum or Plasma by Screen method |
|
550-4
|
Bordetella pertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
25148-8
|
Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field |
|
14117-6
|
IgG index in Serum & CSF |
|
26509-0
|
Neutrophils.band form/100 leukocytes in Cerebral spinal fluid |
|
12209-3
|
Eosinophils/100 leukocytes in Body fluid by Manual count |
|
666-8
|
Microscopic observation [Identifier] in Unspecified specimen by India ink prep |
|
12215-0
|
Fatty acids.very long chain [Moles/volume] in Serum or Plasma |
|
19734-3
|
Chicken droppings IgE Ab [Units/volume] in Serum |
|
2638-5
|
Myelin basic protein [Mass/volume] in Cerebral spinal fluid |
|
14875-9
|
Phenylalanine [Moles/volume] in Serum or Plasma |
|
20643-3
|
Glutamine [Moles/volume] in Serum or Plasma |
|
20636-7
|
Alanine [Moles/volume] in Serum or Plasma |
|
5005-4
|
Epstein Barr virus DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
25473-0
|
Metanephrine [Moles/volume] in Serum or Plasma |
|
20661-5
|
Valine [Moles/volume] in Serum or Plasma |
|
3861-2
|
Nordiazepam [Presence] in Urine |
|
12361-2
|
Oxazepam [Presence] in Urine |
|
15097-9
|
Vanillylmandelate [Moles/volume] in Urine |
|
14121-8
|
Pyruvate [Moles/volume] in Blood |
|
46268-9
|
ABO & Rh group [Type] in Blood from Blood product unit--after transfusion reaction |
|
3436-3
|
Carboxy tetrahydrocannabinol [Mass/volume] in Urine |
|
41163-7
|
Treponema pallidum DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
20648-2
|
Isoleucine [Moles/volume] in Serum or Plasma |
|
20649-0
|
Leucine [Moles/volume] in Serum or Plasma |
|
24139-8
|
Cockroach IgG Ab [Units/volume] in Serum |
|
11183-1
|
Macadamia IgE Ab [Units/volume] in Serum |
|
44607-0
|
HIV 1 [interpretation] in Serum by Immunoassay |
|
8015-0
|
Rubella virus IgM Ab [Units/volume] in Serum |
|
6239-8
|
Lenscale IgE Ab [Units/volume] in Serum |
|
5116-9
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay |
|
1777-2
|
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
|
22568-0
|
Streptolysin O Ab [Titer] in Serum |
|
13538-4
|
Carbon dioxide, total [Moles/volume] in Urine |
|
14976-5
|
Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
|
19201-3
|
Prostate Specific Ag Free [Units/volume] in Serum or Plasma |
|
18482-0
|
Yeast [Presence] in Unspecified specimen by Organism specific culture |
|
32789-0
|
Viscosity of Semen Qualitative |
|
7445-0
|
Lactalbumin alpha IgE Ab [Units/volume] in Serum |
|
35670-9
|
Tobramycin [Mass/volume] in Serum or Plasma |
|
50927-3
|
Tobramycin [Moles/volume] in Serum or Plasma |
|
17819-4
|
Albumin/Protein.total in unspecified time Urine by Electrophoresis |
|
17811-1
|
Alpha 1 globulin/Protein.total in unspecified time Urine by Electrophoresis |
|
17813-7
|
Alpha 2 globulin/Protein.total in unspecified time Urine by Electrophoresis |
|
17815-2
|
Beta globulin/Protein.total in unspecified time Urine by Electrophoresis |
|
17817-8
|
Gamma globulin/Protein.total in unspecified time Urine by Electrophoresis |
|
21027-8
|
Platelet aggregation [interpretation] in Platelet poor plasma |
|
13088-0
|
Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
|
34165-1
|
Granulocytes Immature [Presence] in Blood by Automated count |
|
8072-1
|
Insulin Ab [Units/volume] in Serum |
|
20660-7
|
Tyrosine [Moles/volume] in Serum or Plasma |
|
20401-6
|
Nuclear Ab pattern.speckled [Titer] in Serum |
|
533-0
|
Mycobacterium sp identified in Blood by Organism specific culture |
|
20651-6
|
Methionine [Moles/volume] in Serum or Plasma |
|
9360-9
|
Bartonella quintana IgG Ab [Titer] in Serum |
|
23870-9
|
Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot (IB) |
|
59408-5
|
Oxygen saturation in Arterial blood by Pulse oximetry |
|
14678-7
|
Cortisol [Moles/volume] in Serum or Plasma --evening specimen |
|
15086-2
|
Oxalate [Moles/volume] in Urine |
|
4991-6
|
Borrelia burgdorferi DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
22070-7
|
HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
6286-9
|
Wormwood IgE Ab [Units/volume] in Serum |
|
32220-6
|
Liver kidney microsomal 1 Ab [Units/volume] in Serum |
|
9326-0
|
Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay |
|
9361-7
|
Bartonella quintana IgM Ab [Titer] in Serum |
|
20637-5
|
Arginine [Moles/volume] in Serum or Plasma |
|
20640-9
|
Citrulline [Moles/volume] in Serum or Plasma |
|
20644-1
|
Glycine [Moles/volume] in Serum or Plasma |
|
20656-5
|
Serine [Moles/volume] in Serum or Plasma |
|
20658-1
|
Threonine [Moles/volume] in Serum or Plasma |
|
20657-3
|
Taurine [Moles/volume] in Serum or Plasma |
|
6029-3
|
Aureobasidium pullulans IgE Ab [Units/volume] in Serum |
|
20642-5
|
Glutamate [Moles/volume] in Serum or Plasma |
|
20645-8
|
Histidine [Moles/volume] in Serum or Plasma |
|
20655-7
|
Proline [Moles/volume] in Serum or Plasma |
|
18903-5
|
Chloramphenicol [Susceptibility] |
|
17788-1
|
Large unstained cells/100 leukocytes in Blood by Automated count |
|
14246-3
|
Phosphatidylserine IgM Ab [Units/volume] in Serum |
|
3218-5
|
Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay |
|
49058-1
|
Activated partial thromboplastin time (aPTT) in Blood drawn from CRRT circuit by Coagulation assay |
|
6061-6
|
Carrot IgE Ab [Units/volume] in Serum |
|
20781-1
|
Cryptosporidium sp [Presence] in Stool by Acid fast stain |
|
32217-2
|
von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma |
|
22412-1
|
Saccharopolyspora rectivirgula Ab [Presence] in Serum |
|
20652-4
|
Ornithine [Moles/volume] in Serum or Plasma |
|
6733-0
|
Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
20650-8
|
Lysine [Moles/volume] in Serum or Plasma |
|
10853-0
|
Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
|
5869-3
|
Parainfluenza virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
7059-9
|
Vancomycin [Susceptibility] by Gradient strip |
|
15050-8
|
Creatinine [Moles/volume] in Amniotic fluid |
|
29767-1
|
Bilirubin.total [Moles/volume] in Body fluid |
|
20638-3
|
Asparagine [Moles/volume] in Serum or Plasma |
|
12201-0
|
Cryoglobulin [Presence] in Serum by 1 day cold incubation |
|
20499-0
|
Phosphatidylglycerol/Surfactant.total in Amniotic fluid |
|
50758-2
|
Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
26927-4
|
Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
16195-0
|
Benzodiazepines [Presence] in Urine by Confirmatory method |
|
6081-4
|
Coconut IgE Ab [Units/volume] in Serum |
|
721-1
|
Free Hemoglobin [Mass/volume] in Plasma |
|
31209-0
|
Islet cell 512 Ab [Units/volume] in Serum |
|
1779-8
|
Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma |
|
2334-1
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid |
|
16085-3
|
Wheat IgE Ab RAST class in Serum |
|
29591-5
|
Enterovirus RNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
24103-4
|
Plasma cells [#/volume] in Blood by Manual count |
|
6038-4
|
American Beech IgE Ab [Units/volume] in Serum |
|
38168-1
|
Major crossmatch [interpretation] by Low ionic strenght saline (LISS) |
|
51844-9
|
Cortisol [Moles/volume] in Saliva |
|
15568-9
|
Soybean IgE Ab RAST class in Serum |
|
43734-3
|
aPTT in Platelet poor plasma by Coagulation 1:1 saline |
|
75513-2
|
dRVVT with 1:1 PNP (LA mix) |
|
16982-1
|
HTLV 1+2 Ab [Presence] in Serum by Immunoblot (IB) |
|
20420-6
|
Prostatic acid phosphatase [Mass/volume] in Serum |
|
6125-9
|
Gluten IgE Ab [Units/volume] in Serum |
|
30374-3
|
Basophils/100 leukocytes in Cerebral spinal fluid |
|
14812-2
|
Lidocaine [Moles/volume] in Serum or Plasma |
|
10526-2
|
Microscopic observation [Identifier] in Sputum by Cyto stain |
|
7796-6
|
Platelet clump [Presence] in Blood by Light microscopy |
|
5959-2
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
29559-2
|
Haemophilus ducreyi DNA [Presence] in Unspecified specimen by Probe & target amplification method |
|
18743-5
|
Autopsy report |
|
25447-4
|
Insulin Free [Moles/volume] in Serum or Plasma |
|
6121-8
|
Fusarium moniliforme IgE Ab [Units/volume] in Serum |
|
49838-6
|
Neural tube defect risk in population |
|
6090-5
|
Cottonwood IgE Ab [Units/volume] in Serum |
|
30192-9
|
Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum |
|
6287-7
|
Baker's yeast IgE Ab [Units/volume] in Serum |
|
6349-5
|
Chlamydia trachomatis [Presence] in Unspecified specimen by Organism specific culture |
|
4635-9
|
Free Hemoglobin [Mass/volume] in Serum |
|
46128-5
|
Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay |
|
2711-0
|
Oxygen saturation in Venous blood |
|
7797-4
|
Rouleaux [Presence] in Blood by Light microscopy |
|
8277-6
|
Body surface area |
|
765-8
|
Neutrophils.hypersegmented [Presence] in Blood by Light microscopy |
|
1926-5
|
Base excess in Capillary blood |
|
7795-8
|
Pappenheimer bodies [Presence] in Blood by Light microscopy |
|
20456-0
|
Fungi.yeastlike [Presence] in Urine sediment by Light microscopy |
|
2716-9
|
Fractional oxyhemoglobin in Venous blood |
|
5819-8
|
Waxy casts [#/area] in Urine sediment by Microscopy low power field |
|
5807-3
|
RBC casts [#/area] in Urine sediment by Microscopy low power field |
|
38995-7
|
Mixed cellular casts [#/area] in Urine sediment by Microscopy low power field |
|
46138-4
|
Urate crystals [#/area] in Urine sediment by Microscopy high power field |
|
5335-5
|
Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25154-6
|
Unidentified crystals [#/area] in Urine sediment by Microscopy high power field |
|
33215-5
|
Neutrophils.agranular [Presence] in Blood by Light microscopy |
|
5788-5
|
Oval fat bodies (globules) [#/area] in Urine sediment by Microscopy high power field |
|
2272-3
|
Fat [Presence] in Urine |
|
10380-4
|
Stomatocytes [Presence] in Blood by Light microscopy |
|
7817-0
|
Borrelia burgdorferi IgG Ab [Units/volume] in Serum |
|
5062-5
|
Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay |
|
5786-9
|
Epithelial casts [#/area] in Urine sediment by Microscopy low power field |
|
33216-3
|
Platelets agranular [Presence] in Blood by Light microscopy |
|
18311-1
|
Pelger Huet cells [Presence] in Blood by Light microscopy |
|
11281-3
|
Auer rods [Presence] in Blood by Light microscopy |
|
30003-8
|
Microalbumin [Mass/volume] in 24 hour Urine |
|
5784-4
|
Cystine crystals [Presence] in Urine sediment by Light microscopy |
|
5775-2
|
Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy |
|
5789-3
|
Fatty casts [#/area] in Urine sediment by Microscopy low power field |
|
5773-7
|
Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy |
|
25886-3
|
Creatinine [Moles/volume] in 24 hour Urine |
|
14958-3
|
Microalbumin/Creatinine [Mass ratio] in 24 hour Urine |
|
33647-9
|
Protein.monoclonal/Protein.total in Serum or Plasma by Electrophoresis |
|
716-1
|
Heinz bodies [Presence] in Blood by Light microscopy |
|
5798-4
|
Leucine crystals [Presence] in Urine sediment by Light microscopy |
|
2027-1
|
Carbon dioxide, total [Moles/volume] in Venous blood |
|
5815-6
|
Tyrosine crystals [Presence] in Urine sediment by Light microscopy |
|
5766-1
|
Ammonium urate crystals [Presence] in Urine sediment by Light microscopy |
|
30350-3
|
Hemoglobin [Mass/volume] in Venous blood |
|
27200-5
|
Nuclear Ab [Units/volume] in Serum |
|
25149-6
|
Calcium phosphate crystals [#/area] in Urine sediment by Microscopy high power field |
|
25158-7
|
Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy |
|
18487-9
|
Broad casts [#/area] in Urine sediment by Microscopy low power field |
|
24015-0
|
Influenza virus A+B Ag [Presence] in Unspecified specimen |
|
6437-8
|
Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunoassay |
|
20457-8
|
Fungi.filamentous [Presence] in Urine sediment by Light microscopy |
|
5812-3
|
Sulfonamide crystals [Presence] in Urine sediment by Light microscopy |
|
5771-1
|
Bilirubin crystals [Presence] in Urine sediment by Light microscopy |
|
25147-0
|
Calcium carbonate crystals [#/area] in Urine sediment by Microscopy high power field |
|
40729-6
|
Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay |
|
53835-5
|
1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma |
|
5777-8
|
Cholesterol crystals [Presence] in Urine sediment by Light microscopy |
|
20455-2
|
Leukocytes [Presence] in Urine sediment by Light microscopy |
|
45068-4
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by Probe and target amplification method |
|
33905-1
|
Trichomonas sp [#/area] in Urine sediment by Microscopy high power field |
|
30394-1
|
Granulocytes [#/volume] in Blood |
|
5795-0
|
Hippurate crystals [Presence] in Urine sediment by Light microscopy |
|
18312-9
|
Platelet satellitism [Presence] in Blood by Light microscopy |
|
5776-0
|
Calcium sulfate crystals [Presence] in Urine sediment by Light microscopy |
|
27071-0
|
CD45 cells [#/volume] in Blood |
|
11043-7
|
Cryofibrinogen [Presence] in Plasma |
|
32033-3
|
Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay |
|
20578-1
|
Vancomycin [Mass/volume] in Serum or Plasma |
|
31012-8
|
Vancomycin [Moles/volume] in Serum or Plasma |
|
33256-9
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count |
|
708-8
|
Blasts [#/volume] in Blood by Manual count |
|
18309-5
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count |
|
5156-5
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
51928-0
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
33569-5
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
45142-7
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
43182-5
|
Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
53348-9
|
11-Deoxycorticosterone [Moles/volume] in Dried blood spot |
|
53339-8
|
11-Deoxycortisol [Moles/volume] in Dried blood spot |
|
32854-2
|
17-Hydroxyprogesterone [Presence] in Dried blood spot |
|
38473-5
|
17-Hydroxyprogesterone [Mass/volume] in Dried blood spot |
|
53337-2
|
17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar Ratio] in Dried blood spot |
|
53342-2
|
21-Deoxycortisol [Moles/volume] in Dried blood spot |
|
53182-2
|
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot |
|
53189-7
|
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot |
|
53188-9
|
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot |
|
50106-4
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Dried blood spot |
|
53171-5
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in Dried blood spot |
|
53172-3
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot |
|
50109-8
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot |
|
50113-0
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot |
|
50121-3
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot |
|
50125-4
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot |
|
53201-0
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot |
|
50132-0
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot |
|
53196-2
|
3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot |
|
50281-5
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot |
|
53197-0
|
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot |
|
50157-7
|
Acetylcarnitine (C2) [Moles/volume] in Dried blood spot |
|
53152-5
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in Dried blood spot |
|
53154-1
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in Dried blood spot |
|
53153-3
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in Dried blood spot |
|
53393-5
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in Dried blood spot |
|
46733-2
|
Amino acidemias newborn screen interpretation |
|
53344-8
|
Androstenedione [Moles/volume] in Dried blood spot |
|
47562-4
|
Arginine [Moles/volume] in Dried blood spot |
|
53398-4
|
Arginine/Phenylalanine [Molar ratio] in Dried blood spot |
|
53062-6
|
Argininosuccinate [Moles/volume] in Dried blood spot |
|
53200-2
|
Argininosuccinate/Arginine [Molar ratio] in Dried blood spot |
|
38478-4
|
Biotinidase [Presence] in Dried blood spot |
|
75217-0
|
Biotinidase [Enzymatic activity/volume] in Dried blood spot |
|
38479-2
|
Branched chain keto-acid dehydrogenase complex [Presence] in Dried blood spot |
|
38481-8
|
Carnitine free (C0) [Moles/volume] in Dried blood spot |
|
53236-6
|
Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in Dried blood spot |
|
73700-7
|
CCHD newborn screening interpretation |
|
73697-5
|
CCHD newborn screening protocol used [Type] |
|
54083-1
|
CFTR gene mutations found [Identifier] in Dried blood spot Nominal |
|
14463-4
|
Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
|
14464-2
|
Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
|
14465-9
|
Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
|
45094-0
|
Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture |
|
80367-6
|
Chlamydia trachomatis [Presence] in Rectum by Organism specific culture |
|
70164-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by Probe and target amplification method |
|
6351-1
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
45084-1
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by Probe and target amplification method |
|
45086-6
|
Chlamydia trachomatis DNA [Presence] in Nasopharynx by Probe and target amplification method |
|
80363-5
|
Chlamydia trachomatis DNA [Presence] in Rectum by Probe and target amplification method |
|
53926-2
|
Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe and target amplification method |
|
57288-3
|
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe and target amplification method |
|
80364-3
|
Chlamydia trachomatis rRNA [Presence] in Rectum by Probe and target amplification method |
|
80360-1
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe and target amplification method |
|
80361-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe and target amplification method |
|
80362-7
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe and target amplification method |
|
80365-0
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Rectum by Probe and target amplification method |
|
42892-0
|
Citrulline [Moles/volume] in Dried blood spot |
|
54092-2
|
Citrulline/Arginine [Molar ratio] in Dried blood spot |
|
53157-4
|
Citrulline/Phenylalanine [Molar ratio] in Dried blood spot |
|
53399-2
|
Citrulline/Tyrosine [Molar ratio] in Dried blood spot |
|
57838-5
|
dRVVT W excess phospholipid (LA confirm) |
|
68916-6
|
dRVVT W excess phospholipid actual/?normal (normalized LA confirm) |
|
50410-0
|
dRVVT/?dRVVT W excess phospholipid (screen to confirm ratio) |
|
6683-7
|
Reptilase time |
|
68326-8
|
Reptilase time actual/?Normal |
|
34571-0
|
aPTT.lupus sensitive (LA screen) |
|
48022-8
|
aPTT.lupus sensitive actual/?normal (normalized LA screen) |
|
75507-4
|
aPTT.lupus sensitive W excess phospholipid percent correction |
|
75510-8
|
aPTT.lupus sensitive with 1:1 PNP (LA mix) |
|
75509-0
|
aPTT.lupus sensitive with 1:1 PNP actual/?Normal (normalized LA mix) |
|
75506-6
|
aPTT.lupus sensitive W excess phospholipid (LA confirm) |
|
75508-2
|
aPTT.lupus sensitive W excess phospholipid actual/?Normal (normalized LA confirm) |
|
75884-7
|
aPTT.lupus sensitive/?aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio) |
|
68325-0
|
Thrombin time actual/?Normal |
|
5894-1
|
Prothrombin time (PT) actual/?Normal |
|
53346-3
|
Cortisol [Moles/volume] in Dried blood spot |
|
46769-6
|
Cystic fibrosis newborn screen interpretation |
|
45197-1
|
Decanoylcarnitine (C10) [Moles/volume] in Dried blood spot |
|
45198-9
|
Decenoylcarnitine (C10:1) [Moles/volume] in Dried blood spot |
|
45199-7
|
Dodecanoylcarnitine (C12) [Moles/volume] in Dried blood spot |
|
45200-3
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Dried blood spot |
|
75511-6
|
dRVVT W excess phospholipid percent correction |
|
46735-7
|
Endocrine disorders newborn screen interpretation |
|
46736-5
|
Fatty acid oxidation defects newborn screen interpretation |
|
64121-7
|
Fifth most predominant hemoglobin in Dried blood spot |
|
64120-9
|
Fourth most predominant hemoglobin in Dried blood spot |
|
54085-6
|
Galactose [Moles/volume] in Dried blood spot |
|
33288-2
|
Galactose 1 phosphate uridyl transferase [Presence] in Dried blood spot |
|
42906-8
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Dried blood spot |
|
46737-3
|
Galactosemias newborn screen interpretation |
|
53183-0
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Dried blood spot |
|
53184-8
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot |
|
53403-2
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot |
|
53185-5
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot |
|
53186-3
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot |
|
67710-4
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Dried blood spot |
|
67711-2
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot |
|
67701-3
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot |
|
46740-7
|
Hemoglobin disorders newborn screen interpretation |
|
64122-5
|
Hemoglobins that can be presumptively identified based on available controls in Dried blood spot |
|
45211-0
|
Hexanoylcarnitine (C6) [Moles/volume] in Dried blood spot |
|
38486-7
|
Homocystine [Presence] in Dried blood spot |
|
19111-4
|
Mother's hospital number |
|
45216-9
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Dried blood spot |
|
53239-0
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot |
|
53238-2
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Dried blood spot |
|
53401-6
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot |
|
53240-8
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot |
|
45217-7
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot |
|
46779-5
|
Medium/Short chain acyl-CoA dehydrogenase deficiency newborn screen interpretation |
|
47700-0
|
Methionine [Moles/volume] in Dried blood spot |
|
53397-6
|
Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in Dried blood spot |
|
53156-6
|
Methionine/Phenylalanine [Molar ratio] in Dried blood spot |
|
53187-1
|
Methylglutarylcarnitine (C6-DC) [Moles/volume] in Dried blood spot |
|
45222-7
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Dried blood spot |
|
53181-4
|
Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot |
|
67709-6
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Dried blood spot |
|
64117-5
|
Most predominant hemoglobin in Dried blood spot |
|
30099-6
|
Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture |
|
688-2
|
Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture |
|
693-2
|
Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture |
|
697-3
|
Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture |
|
80368-4
|
Neisseria gonorrhoeae [Presence] in Rectum by Organism specific culture |
|
21415-5
|
Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe and target amplification method |
|
32705-6
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen |
|
53879-3
|
Neisseria gonorrhoeae Ag [Presence] in Urethra |
|
57289-1
|
Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by Probe and target amplification method |
|
80366-8
|
Neisseria gonorrhoeae rRNA [Presence] in Rectum by Probe and target amplification method |
|
43384-7
|
Neisseria sp identified in Urethra by Organism specific culture |
|
80369-2
|
Neisseria sp identified in Rectum by Organism specific culture |
|
54108-6
|
Newborn hearing screen of Ear - left |
|
54109-4
|
Newborn hearing screen of Ear - right |
|
54106-0
|
Newborn hearing screen method |
|
49544-0
|
Newborn screening recommended follow-up [interpretation] |
|
77018-0
|
Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
|
77019-8
|
Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
|
75547-0
|
Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
|
73967-2
|
Noninvasive prenatal fetal aneuploidy test panel - Plasma cell-free DNA |
|
53175-6
|
Octanoylcarnitine (C8) [Moles/volume] in Dried blood spot |
|
53176-4
|
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot |
|
53177-2
|
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot |
|
53202-8
|
Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot |
|
46744-9
|
Organic acidemias newborn screen interpretation |
|
59407-7
|
Oxygen saturation in Blood Preductal by Pulse oximetry |
|
59418-4
|
Oxygen saturation in Blood Postductal by Pulse oximetry |
|
73696-7
|
Oxygen saturation.preductal-oxygen saturation.postductal [Mass fraction difference] in Bld.preductal and Bld.postductal |
|
53198-8
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot |
|
53199-6
|
Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot |
|
29571-7
|
Phenylalanine [Presence] in Dried blood spot |
|
29573-3
|
Phenylalanine [Moles/volume] in Dried blood spot |
|
35572-7
|
Phenylalanine/Tyrosine [Molar ratio] in Dried blood spot |
|
53160-8
|
Propionylcarnitine (C3) [Moles/volume] in Dried blood spot |
|
53163-2
|
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot |
|
53162-4
|
Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in Dried blood spot |
|
53164-0
|
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot |
|
75211-3
|
Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot |
|
49048-2
|
Protein feed time |
|
64118-3
|
Second most predominant hemoglobin in Dried blood spot |
|
46765-4
|
Sickle cell anemia newborn screen interpretation |
|
53241-6
|
Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot |
|
53231-7
|
Succinylacetone [Moles/volume] in Dried blood spot |
|
62320-7
|
T-cell receptor excision circle [#/volume] in Dried blood spot by Probe and target amplification method |
|
53190-5
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Dried blood spot |
|
53192-1
|
Tetradecanoylcarnitine (C14) [Moles/volume] in Dried blood spot |
|
53191-3
|
Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot |
|
53193-9
|
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot |
|
53194-7
|
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Dried blood spot |
|
53195-4
|
Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot |
|
70159-9
|
Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in Dried blood spot |
|
64119-1
|
Third most predominant hemoglobin in Dried blood spot |
|
47784-4
|
Threonine [Moles/volume] in Dried blood spot |
|
29574-1
|
Thyrotropin [Presence] in Dried blood spot |
|
29575-8
|
Thyrotropin [Units/volume] in Dried blood spot |
|
31145-6
|
Thyroxine (T4) [Moles/volume] in Dried blood spot |
|
38506-2
|
Thyroxine (T4) [Presence] in Dried blood spot |
|
48633-2
|
Trypsinogen I Free [Mass/volume] in Dried blood spot |
|
53159-0
|
Tryptophan [Moles/volume] in Dried blood spot |
|
35571-9
|
Tyrosine [Moles/volume] in Dried blood spot |
|
47799-2
|
Valine [Moles/volume] in Dried blood spot |
|
53151-7
|
Valine/Phenylalanine [Molar ratio] in Dried blood spot |